| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CDHR5 ACTN1 ADGRV1 RYR2 IQGAP1 ITPR3 FAT2 CDH20 PLCB1 PLCG1 VLDLR FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CHORDC1 SELENON SLC8A1 THBS4 SLIT3 CABS1 MACF1 UNC13C CDH6 | 1.99e-06 | 749 | 341 | 32 | GO:0005509 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PDGFRA PDK2 PDK3 CDK19 MAP3K20 PAPOLB FGFRL1 AK6 AK9 PTDSS2 ERVK-10 POLA2 NEK9 MLKL PNPT1 TTBK2 PIK3CA TJP2 PRKAG2 WNK3 ROCK2 CDC42BPA POLRMT PI4KAP2 LRRK1 REV3L CIT NMNAT3 AATK GUCY2F EPHA2 FLAD1 TNKS ATM IPMK | 1.29e-05 | 938 | 341 | 35 | GO:0016772 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | TRPC4 CDHR5 ACTN1 GFAP HNRNPK IQGAP1 PTPRB CDH20 PTPRF NRXN2 TJP2 FGG CD200 SFN COL5A1 NRCAM DSG2 TNC DBNL THBS4 EPHA2 MACF1 CDH6 PLIN3 PHLDB2 HDLBP | 1.43e-05 | 599 | 341 | 26 | GO:0050839 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IQGAP2 ARHGEF11 GDI1 IQGAP1 ASAP2 ARHGAP31 ARHGAP29 PLCB1 PLCG1 GNAQ HERC1 LAMTOR2 GPS1 OCRL SYDE1 RGS12 OPHN1 ARHGEF40 ARHGEF33 FARP1 PLCE1 | 1.84e-04 | 507 | 341 | 21 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IQGAP2 ARHGEF11 GDI1 IQGAP1 ASAP2 ARHGAP31 ARHGAP29 PLCB1 PLCG1 GNAQ HERC1 LAMTOR2 GPS1 OCRL SYDE1 RGS12 OPHN1 ARHGEF40 ARHGEF33 FARP1 PLCE1 | 1.84e-04 | 507 | 341 | 21 | GO:0030695 |
| GeneOntologyMolecularFunction | kinase binding | MAP2 CENPE ACTA2 NEK9 GFAP GADD45A RYR2 IQGAP1 MLKL STXBP1 PTPRF TJP2 DLG3 KIF2A PLCG1 PLCG2 PRKAG2 SFN CASS4 ATN1 TTC28 RBBP6 APBA1 RICTOR BCAR1 CIT OPA1 CRK ELAVL1 AKAP11 CDC25C HTT | 2.93e-04 | 969 | 341 | 32 | GO:0019900 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR5 FAT2 CDH20 PTPRF FAT4 NRCAM DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 2.38e-09 | 187 | 342 | 18 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell junction organization | ADGRB1 MPDZ EXT1 LRRTM1 ACTN1 GRHL2 HNRNPK IQGAP1 CDH20 PTPRF NRXN2 TJP2 VSTM5 BSN ROCK2 VLDLR CUX2 LAMTOR2 NRCAM ABI3BP DSG2 TNC UBE3B PCDHB13 SLITRK4 DBNL EPB41L5 APOE OPA1 MFN1 CRK OPHN1 LRRN3 FARP1 EPHA2 MACF1 CDH6 PDZRN3 PHLDB2 CACNA2D3 | 1.26e-07 | 974 | 342 | 40 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FGFRL1 CDHR5 FAT2 CDH20 PTPRF FAT4 NRCAM DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 COLEC10 CDH6 | 3.13e-07 | 313 | 342 | 20 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell junction assembly | ADGRB1 MPDZ LRRTM1 ACTN1 GRHL2 IQGAP1 CDH20 NRXN2 VSTM5 BSN ROCK2 VLDLR CUX2 NRCAM ABI3BP UBE3B PCDHB13 SLITRK4 DBNL EPB41L5 CRK OPHN1 LRRN3 FARP1 EPHA2 MACF1 CDH6 PHLDB2 | 3.32e-07 | 569 | 342 | 28 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PDGFRA PKD1L1 FGFRL1 CDHR5 EXT1 ACTN1 ADGRV1 FAT2 STXBP1 CDH20 PTPRF NRXN2 PIK3CA DHPS TJP2 DLG3 FGG CD200 FAT4 NRCAM DSG2 PCDHGB2 PCDHGA11 PCDHGA10 KIF26B PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 EPB41L5 PCDHA4 BTLA COLEC10 OPA1 THBS4 CD80 CDH6 | 4.07e-06 | 1077 | 342 | 39 | GO:0098609 |
| GeneOntologyBiologicalProcess | postsynapse organization | ADGRB1 LRRTM1 ACTN1 HNRNPK PTPRF NRXN2 ROCK2 CUX2 NRCAM ABI3BP UBE3B DBNL APOE OPA1 MFN1 CRK OPHN1 FARP1 | 5.42e-06 | 313 | 342 | 18 | GO:0099173 |
| GeneOntologyBiologicalProcess | embryo development | A2M ZFP42 UPB1 PDGFRA MAP3K20 EXT1 GRHL2 RXRB ADCY9 RYR2 PRDM1 TTBK2 FREM2 PTPRQ PLCB1 CC2D2A DLG3 C5 PLCG1 GNAQ TDRD6 ROCK2 COL5A1 FRAS1 ZEB1 RBBP6 AFF3 APBA1 NSD1 EPB41L5 RICTOR COLEC10 OCRL DICER1 OPA1 CCDC39 SYDE1 SLC8A1 GDF7 EPHA2 TTLL4 MACF1 ATM IPMK COQ7 PHLDB2 HTT | 6.17e-06 | 1437 | 342 | 47 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | ADGRB1 LRRTM1 HNRNPK PTPRF NRXN2 VSTM5 ROCK2 VLDLR CUX2 NRCAM ABI3BP UBE3B SLITRK4 DBNL APOE OPA1 MFN1 LRRN3 FARP1 CACNA2D3 | 8.12e-06 | 387 | 342 | 20 | GO:0050807 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MAP2 ADGRB1 EXT1 ACTN1 LARP4 GDI1 GRHL2 HNRNPK IQGAP1 TTC8 STXBP1 CDH20 PTPRF PTPRQ MOV10 ROCK2 VLDLR CUX2 NRCAM ABI3BP SLITRK4 DBNL EPB41L5 APOE CIT DICER1 OPA1 MFN1 CRK OPHN1 THBS4 ARHGEF40 GDF7 FARP1 EPHA2 SLIT3 MACF1 CDH6 ZMYM6 EPB42 USP33 | 8.21e-06 | 1194 | 342 | 41 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | ADGRB1 LRRTM1 HNRNPK PTPRF NRXN2 VSTM5 ROCK2 VLDLR CUX2 NRCAM ABI3BP UBE3B SLITRK4 DBNL APOE OPA1 MFN1 LRRN3 FARP1 CACNA2D3 | 1.10e-05 | 395 | 342 | 20 | GO:0050803 |
| GeneOntologyBiologicalProcess | synapse organization | ADGRB1 LRRTM1 ACTN1 HNRNPK PTPRF NRXN2 VSTM5 BSN ROCK2 VLDLR CUX2 NRCAM ABI3BP TNC UBE3B PCDHB13 SLITRK4 DBNL APOE OPA1 MFN1 CRK OPHN1 LRRN3 FARP1 CDH6 PDZRN3 CACNA2D3 | 1.18e-05 | 685 | 342 | 28 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | ADGRB1 LRRTM1 IQGAP1 NRXN2 VSTM5 ROCK2 VLDLR CUX2 ABI3BP UBE3B SLITRK4 EPB41L5 LRRN3 FARP1 EPHA2 MACF1 PHLDB2 | 1.75e-05 | 309 | 342 | 17 | GO:1901888 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | PDGFRA ACTA1 ACTA2 ACTC1 EXT1 GRHL2 RYR2 TTC8 FREM2 CC2D2A DLG3 ROCK2 COL5A1 FAT4 FRAS1 TNC KIF26B EPB41L5 DICER1 OPA1 CCDC39 OPHN1 GDF7 EPHA2 MACF1 IPMK COQ7 PHLDB2 HTT | 2.30e-05 | 750 | 342 | 29 | GO:0048729 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MAP2 ADGRB1 EXT1 GDI1 HNRNPK IQGAP1 TTC8 STXBP1 PTPRF MOV10 ROCK2 VLDLR CUX2 NRCAM ABI3BP SLITRK4 DBNL APOE CIT DICER1 OPA1 MFN1 OPHN1 THBS4 ARHGEF40 GDF7 FARP1 SLIT3 MACF1 USP33 | 3.08e-05 | 802 | 342 | 30 | GO:0048812 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 3.99e-05 | 24 | 342 | 5 | GO:0048015 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | PDGFRA EXT1 GRHL2 RYR2 TTC8 FREM2 CC2D2A DLG3 ROCK2 COL5A1 FAT4 FRAS1 TNC KIF26B EPB41L5 DICER1 OPA1 CCDC39 OPHN1 GDF7 EPHA2 IPMK COQ7 PHLDB2 HTT | 4.25e-05 | 619 | 342 | 25 | GO:0002009 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 4.41e-05 | 5 | 342 | 3 | GO:0090131 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MAP2 ADGRB1 EXT1 GDI1 HNRNPK IQGAP1 TTC8 STXBP1 PTPRF MOV10 ROCK2 VLDLR CUX2 NRCAM ABI3BP SLITRK4 DBNL APOE CIT DICER1 OPA1 MFN1 OPHN1 THBS4 ARHGEF40 GDF7 FARP1 SLIT3 MACF1 USP33 | 4.53e-05 | 819 | 342 | 30 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MAP2 ADGRB1 EXT1 GDI1 HNRNPK IQGAP1 TTC8 STXBP1 PTPRF MOV10 ROCK2 VLDLR CUX2 NRCAM ABI3BP SLITRK4 DBNL APOE CIT DICER1 OPA1 MFN1 OPHN1 THBS4 ARHGEF40 GDF7 FARP1 SLIT3 MACF1 USP33 | 5.29e-05 | 826 | 342 | 30 | GO:0048858 |
| GeneOntologyBiologicalProcess | actin filament-based process | PDGFRA IQGAP2 ACTA1 ACTA2 ADGRB1 ACTC1 ACTN1 ARHGEF11 RYR2 IQGAP1 TTC8 PIK3CA FGF12 ROCK2 CDC42BPA ABI3BP DSG2 SGCD PPM1E DBNL EPB41L5 RICTOR BCAR1 CIT SYDE1 CRK OPHN1 ARPC2 FARP1 FHOD1 AKAP11 PHLDB2 | 5.72e-05 | 912 | 342 | 32 | GO:0030029 |
| GeneOntologyBiologicalProcess | synapse assembly | ADGRB1 LRRTM1 NRXN2 VSTM5 BSN VLDLR CUX2 NRCAM ABI3BP UBE3B PCDHB13 SLITRK4 DBNL CRK LRRN3 FARP1 | 6.14e-05 | 308 | 342 | 16 | GO:0007416 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | PDGFRA MAP3K20 EXT1 GRHL2 RYR2 TTBK2 FREM2 PTPRQ CC2D2A GNAQ ROCK2 COL5A1 FRAS1 ZEB1 AFF3 NSD1 EPB41L5 DICER1 OPA1 CCDC39 GDF7 EPHA2 MACF1 IPMK COQ7 PHLDB2 HTT | 6.31e-05 | 713 | 342 | 27 | GO:0048598 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | LRRTM1 HNRNPK PTPRF NRXN2 CUX2 NRCAM ABI3BP UBE3B DBNL APOE OPA1 MFN1 | 6.40e-05 | 185 | 342 | 12 | GO:0099175 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | PDGFRA CENPE GADD45A TERF2IP IQGAP1 PTPRB PIK3CA PTPRQ DLG3 PLCG2 GNAQ PRKAG2 HSPA4 WNK3 SFN CASS4 ROCK2 VLDLR PPM1E NSD1 XDH RICTOR AIDA LRRK1 APOE CHORDC1 DICER1 LEPR IFNAR1 LRRN3 SLC8A1 THBS4 CD80 AKAP11 CDC25C HTT | 1.46e-04 | 1133 | 342 | 36 | GO:0001932 |
| GeneOntologyBiologicalProcess | inositol trisphosphate metabolic process | 1.49e-04 | 17 | 342 | 4 | GO:0032957 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | PDGFRA CENPE GADD45A TERF2IP IQGAP1 PTPRB PIK3CA PTPRQ DLG3 PLCG2 GNAQ PRKAG2 HSPA4 WNK3 SFN CASS4 ROCK2 VLDLR PPM1E NSD1 XDH BIRC3 RICTOR AIDA LRRK1 APOE CHORDC1 DICER1 LEPR IFNAR1 LRRN3 SLC8A1 THBS4 CD80 EPHA2 AKAP11 CDC25C HTT | 1.57e-04 | 1226 | 342 | 38 | GO:0042325 |
| GeneOntologyBiologicalProcess | dendrite development | MAP2 MPDZ HNRNPK IQGAP1 PTPRF ROCK2 VLDLR CUX2 ABI3BP DBNL APOE CIT OPA1 MFN1 CRK FARP1 | 1.63e-04 | 335 | 342 | 16 | GO:0016358 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | RYR2 ITPR3 PLCB1 PLCG1 PLCG2 SELENON SLC8A1 DHRS7C HTT PLCE1 | 1.66e-04 | 146 | 342 | 10 | GO:0051209 |
| GeneOntologyBiologicalProcess | heart development | PDGFRA PKD1L1 ACTC1 FGFRL1 EXT1 GRHL2 RXRB RYR2 PRDM1 FREM2 CC2D2A FGF12 GNAQ DNAH5 ODAD3 ROCK2 COL5A1 FAT4 ABI3BP DSG2 SGCD IFT74 DICER1 CCDC39 SLC8A1 SLIT3 ATM | 1.69e-04 | 757 | 342 | 27 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | RYR2 ITPR3 PLCB1 PLCG1 PLCG2 SELENON SLC8A1 DHRS7C HTT PLCE1 | 1.76e-04 | 147 | 342 | 10 | GO:0051283 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABCB7 MAP2 ADGRB1 LRRTM1 GFAP IQGAP1 TTC8 TTBK2 STXBP1 NRXN2 SACS PIK3CA PLCG2 VSTM5 ODAD3 ROCK2 VLDLR CUX2 ABI3BP UBE3B PPM1E SLITRK4 DBNL EPB41L5 RICTOR AIDA APOE ARPC2 LRRN3 FARP1 EPHA2 FHOD1 MACF1 ATM PHLDB2 HTT PLCE1 | 1.78e-04 | 1189 | 342 | 37 | GO:0044087 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ZFP42 UPB1 PDGFRA EXT1 GRHL2 RXRB ADCY9 PRDM1 TTBK2 CC2D2A C5 PLCG1 ROCK2 ZEB1 RBBP6 APBA1 EPB41L5 RICTOR COLEC10 OCRL DICER1 OPA1 SYDE1 SLC8A1 GDF7 EPHA2 TTLL4 ATM IPMK COQ7 HTT | 1.84e-04 | 929 | 342 | 31 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | RYR2 ITPR3 PLCB1 PLCG1 PLCG2 SELENON SLC8A1 DHRS7C HTT PLCE1 | 1.96e-04 | 149 | 342 | 10 | GO:0051282 |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | RYR2 ITPR3 PLCB1 PLCG1 PLCG2 SELENON SLC8A1 DHRS7C HTT PLCE1 | 2.43e-04 | 153 | 342 | 10 | GO:0051208 |
| GeneOntologyBiologicalProcess | negative regulation of microtubule binding | 2.74e-04 | 2 | 342 | 2 | GO:1904527 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification to peptidyl-hypusine | 2.74e-04 | 2 | 342 | 2 | GO:0008612 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 2.92e-04 | 20 | 342 | 4 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 2.92e-04 | 20 | 342 | 4 | GO:1903140 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | ADGRB1 LRRTM1 IQGAP1 TTBK2 PIK3CA PLCG2 VSTM5 ROCK2 CUX2 PPM1E SLITRK4 EPB41L5 RICTOR APOE ARPC2 LRRN3 EPHA2 FHOD1 ATM PHLDB2 HTT PLCE1 | 3.09e-04 | 582 | 342 | 22 | GO:0044089 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MAP2 ADGRB1 EXT1 GDI1 TTC8 STXBP1 PTPRF PTPRQ ROCK2 VLDLR CUX2 NRCAM ABI3BP SLITRK4 DBNL APOE CIT OPA1 MFN1 OPHN1 ARHGEF40 GDF7 FARP1 SLIT3 MACF1 USP33 | 3.31e-04 | 748 | 342 | 26 | GO:0048667 |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 3.54e-04 | 57 | 342 | 6 | GO:0030865 | |
| GeneOntologyBiologicalProcess | neuron development | MAP2 ADGRB1 MPDZ EXT1 ADGRV1 GDI1 GFAP HNRNPK IQGAP1 PRDM1 TTC8 STXBP1 PTPRF PTPRQ KIF3C GNAQ HERC1 MOV10 ROCK2 VLDLR FAT4 CUX2 NRCAM ABI3BP TNC SLITRK4 DBNL APOE CIT DICER1 OPA1 MFN1 CRK OPHN1 THBS4 ARHGEF40 GDF7 FARP1 SLIT3 MACF1 USP33 HTT | 3.60e-04 | 1463 | 342 | 42 | GO:0048666 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | MAP2 ARHGEF11 TTC8 DLG3 ROCK2 ATN1 KIF26B RICTOR CRK OPHN1 MACF1 PHLDB2 HTT | 3.84e-04 | 257 | 342 | 13 | GO:0007163 |
| GeneOntologyBiologicalProcess | neuron projection development | MAP2 ADGRB1 MPDZ EXT1 ADGRV1 GDI1 GFAP HNRNPK IQGAP1 TTC8 STXBP1 PTPRF KIF3C HERC1 MOV10 ROCK2 VLDLR FAT4 CUX2 NRCAM ABI3BP TNC SLITRK4 DBNL APOE CIT DICER1 OPA1 MFN1 CRK OPHN1 THBS4 ARHGEF40 GDF7 FARP1 SLIT3 MACF1 USP33 | 3.97e-04 | 1285 | 342 | 38 | GO:0031175 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | PDGFRA IQGAP2 ACTA1 ADGRB1 ACTC1 ACTN1 ARHGEF11 IQGAP1 TTC8 PIK3CA ROCK2 CDC42BPA ABI3BP PPM1E DBNL EPB41L5 RICTOR BCAR1 CIT SYDE1 CRK OPHN1 ARPC2 FARP1 FHOD1 AKAP11 PHLDB2 | 4.28e-04 | 803 | 342 | 27 | GO:0030036 |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 4.51e-04 | 136 | 342 | 9 | GO:1901890 | |
| GeneOntologyBiologicalProcess | diacylglycerol biosynthetic process | 4.97e-04 | 10 | 342 | 3 | GO:0006651 | |
| GeneOntologyCellularComponent | cell leading edge | IQGAP2 MAP2 ACTA1 ACTA2 ACTC1 ACTN1 ADGRV1 IQGAP1 ARHGAP31 PIK3CA PLCG1 PLCG2 CDC42BPA ATN1 ABI3BP DBNL EPB41L5 BCAR1 CIT ARPC2 EPHA2 MACF1 PHLDB2 PLCE1 | 3.19e-06 | 500 | 344 | 24 | GO:0031252 |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP2 SLC6A17 ADGRB1 ANKS1B ACTC1 MPDZ LRRTM1 ACTN1 HNRNPK STXBP1 NRXN2 PLCB1 DLG3 PLCG1 BSN ROCK2 VLDLR NRCAM UBE3B SLITRK4 DBNL APBA1 APOE GRM4 DICER1 OPHN1 ARPC2 FARP1 ELAVL1 CDH6 HTT | 1.50e-05 | 817 | 344 | 31 | GO:0098978 |
| GeneOntologyCellularComponent | lamellipodium | IQGAP2 ACTA1 ACTA2 ACTC1 ARHGAP31 PIK3CA PLCG1 CDC42BPA ABI3BP DBNL BCAR1 ARPC2 EPHA2 PLCE1 | 2.98e-05 | 230 | 344 | 14 | GO:0030027 |
| GeneOntologyCellularComponent | anchoring junction | TRPC4 ADGRB1 ACTC1 MPDZ FGFRL1 IRF2 ACTN1 GRHL2 HNRNPK IQGAP1 FAT2 CDH20 ARHGAP31 PIK3CA TJP2 DLG3 PLCG1 WNK3 CASS4 CDC42BPA ATN1 DSG2 TNC MPZL1 DBNL EPB41L5 BCAR1 ARPC2 SLC8A1 EPHA2 FHOD1 CDH6 PHLDB2 USP33 | 3.32e-05 | 976 | 344 | 34 | GO:0070161 |
| GeneOntologyCellularComponent | lipoprotein particle | 7.92e-05 | 44 | 344 | 6 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 7.92e-05 | 44 | 344 | 6 | GO:0034358 | |
| GeneOntologyCellularComponent | protein-lipid complex | 1.16e-04 | 47 | 344 | 6 | GO:0032994 | |
| GeneOntologyCellularComponent | ruffle | MAP2 ACTN1 IQGAP1 PLCG1 PLCG2 DBNL EPB41L5 BCAR1 CIT ARPC2 EPHA2 MACF1 | 1.66e-04 | 206 | 344 | 12 | GO:0001726 |
| GeneOntologyCellularComponent | high-density lipoprotein particle | 2.54e-04 | 35 | 344 | 5 | GO:0034364 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | RYR2 STXBP1 CDH20 PIK3CA GNAQ BSN APOE ARHGEF40 FARP1 ATM CDH6 COQ7 | 4.54e-04 | 230 | 344 | 12 | GO:0019898 |
| GeneOntologyCellularComponent | dendrite | MAP2 ADGRB1 ANKS1B PSMC2 MPDZ ACTN1 ADCY9 HNRNPK ITPR3 SACS DLG3 KIF3C GNAQ VSTM5 BSN ABI3BP DBNL APBA1 APOE GRM4 DICER1 OPA1 RGS12 OPHN1 ARPC2 SLC8A1 FARP1 HTT | 4.78e-04 | 858 | 344 | 28 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MAP2 ADGRB1 ANKS1B PSMC2 MPDZ ACTN1 ADCY9 HNRNPK ITPR3 SACS DLG3 KIF3C GNAQ VSTM5 BSN ABI3BP DBNL APBA1 APOE GRM4 DICER1 OPA1 RGS12 OPHN1 ARPC2 SLC8A1 FARP1 HTT | 4.96e-04 | 860 | 344 | 28 | GO:0097447 |
| GeneOntologyCellularComponent | presynaptic active zone | 5.56e-04 | 141 | 344 | 9 | GO:0048786 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SNPH MAP2 ADGRB1 ANKS1B PSMC2 MPDZ ACTN1 GDI1 ADCY9 HNRNPK ITPR3 PTPRF SACS DLG3 KIF3C GNAQ VSTM5 BSN CD200 ABI3BP DBNL APBA1 APOE GRM4 CIT DICER1 OPA1 RGS12 OPHN1 NMNAT3 ARPC2 SLC8A1 FARP1 WDFY3 USP33 HTT | 5.81e-04 | 1228 | 344 | 36 | GO:0036477 |
| GeneOntologyCellularComponent | triglyceride-rich plasma lipoprotein particle | 5.90e-04 | 24 | 344 | 4 | GO:0034385 | |
| GeneOntologyCellularComponent | very-low-density lipoprotein particle | 5.90e-04 | 24 | 344 | 4 | GO:0034361 | |
| GeneOntologyCellularComponent | cell-cell junction | TRPC4 ADGRB1 MPDZ FGFRL1 ACTN1 GRHL2 IQGAP1 FAT2 CDH20 PIK3CA TJP2 DLG3 PLCG1 WNK3 CDC42BPA DSG2 EPB41L5 SLC8A1 EPHA2 FHOD1 CDH6 | 8.49e-04 | 591 | 344 | 21 | GO:0005911 |
| GeneOntologyCellularComponent | axon | PDGFRA MAP2 LRRTM1 GDI1 ADCY9 HNRNPK IQGAP1 STXBP1 PTPRF SACS DLG3 KIF3C VSTM5 BSN CD200 NRCAM BCAR1 GRM4 DICER1 OPA1 SYDE1 OPHN1 NMNAT3 ARPC2 SLC8A1 UNC13C WDFY3 HTT | 8.55e-04 | 891 | 344 | 28 | GO:0030424 |
| GeneOntologyCellularComponent | cell-cell contact zone | 9.25e-04 | 94 | 344 | 7 | GO:0044291 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.28e-03 | 73 | 344 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.38e-03 | 74 | 344 | 6 | GO:0043198 | |
| GeneOntologyCellularComponent | postsynapse | MAP2 SLC6A17 ADGRB1 ANKS1B PSMC2 MPDZ LRRTM1 ACTN1 HNRNPK STXBP1 PTPRF PLCB1 DLG3 BSN CD200 ROCK2 NRCAM ABI3BP UBE3B PCDHB13 DBNL APBA1 DICER1 OPHN1 ARPC2 SLC8A1 FARP1 ELAVL1 MACF1 HTT | 1.54e-03 | 1018 | 344 | 30 | GO:0098794 |
| Domain | CA | CDHR5 FREM2 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 2.94e-11 | 115 | 339 | 17 | SM00112 |
| Domain | Cadherin | CDHR5 FREM2 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 4.49e-11 | 118 | 339 | 17 | IPR002126 |
| Domain | Cadherin_CS | CDHR5 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 1.26e-10 | 109 | 339 | 16 | IPR020894 |
| Domain | CADHERIN_1 | CDHR5 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 2.20e-10 | 113 | 339 | 16 | PS00232 |
| Domain | - | CDHR5 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 2.52e-10 | 114 | 339 | 16 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDHR5 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 2.52e-10 | 114 | 339 | 16 | PS50268 |
| Domain | Cadherin-like | CDHR5 FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 3.28e-10 | 116 | 339 | 16 | IPR015919 |
| Domain | Cadherin | FAT2 CDH20 FAT4 DSG2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 CDH6 | 2.04e-09 | 113 | 339 | 15 | PF00028 |
| Domain | Cadherin_C | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 | 5.06e-08 | 42 | 339 | 9 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 | 5.06e-08 | 42 | 339 | 9 | PF16492 |
| Domain | Cadherin_2 | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 2.51e-07 | 65 | 339 | 10 | PF08266 |
| Domain | Cadherin_N | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 2.51e-07 | 65 | 339 | 10 | IPR013164 |
| Domain | Cadherin_tail | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHA4 | 2.65e-07 | 37 | 339 | 8 | PF15974 |
| Domain | Cadherin_CBD | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHA4 | 2.65e-07 | 37 | 339 | 8 | IPR031904 |
| Domain | Calx_beta | 7.05e-06 | 8 | 339 | 4 | SM00237 | |
| Domain | Calx_beta | 1.25e-05 | 9 | 339 | 4 | IPR003644 | |
| Domain | Calx-beta | 1.25e-05 | 9 | 339 | 4 | PF03160 | |
| Domain | PLCYc | 1.24e-04 | 15 | 339 | 4 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.24e-04 | 15 | 339 | 4 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.24e-04 | 15 | 339 | 4 | PS50008 | |
| Domain | EF-hand_like | 1.24e-04 | 15 | 339 | 4 | PF09279 | |
| Domain | PI-PLC-Y | 1.24e-04 | 15 | 339 | 4 | PF00387 | |
| Domain | PI-PLC_fam | 1.24e-04 | 15 | 339 | 4 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.24e-04 | 15 | 339 | 4 | IPR015359 | |
| Domain | PLCXc | 2.67e-04 | 18 | 339 | 4 | SM00148 | |
| Domain | PI-PLC-X | 2.67e-04 | 18 | 339 | 4 | PF00388 | |
| Domain | ACTINS_1 | 3.10e-04 | 8 | 339 | 3 | PS00406 | |
| Domain | PH_dom-like | ANKS1B ARHGEF11 MTMR10 ASAP2 PLCB1 PLCG1 PLCG2 ROCK2 CDC42BPA APBA1 EPB41L5 CIT RGS12 OPHN1 ARHGEF40 FARP1 WDFY3 PHLDB2 PLCE1 | 3.12e-04 | 426 | 339 | 19 | IPR011993 |
| Domain | A1A_glycop | 3.28e-04 | 2 | 339 | 2 | IPR001500 | |
| Domain | PLC-gamma | 3.28e-04 | 2 | 339 | 2 | IPR016279 | |
| Domain | PIPLC_X_DOMAIN | 3.33e-04 | 19 | 339 | 4 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 3.33e-04 | 19 | 339 | 4 | IPR000909 | |
| Domain | - | 3.35e-04 | 95 | 339 | 8 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 5.87e-04 | 38 | 339 | 5 | PS50025 | |
| Domain | Laminin_G | 6.26e-04 | 58 | 339 | 6 | IPR001791 | |
| Domain | HEAT | 6.26e-04 | 58 | 339 | 6 | IPR000357 | |
| Domain | Laminin_G_2 | 7.47e-04 | 40 | 339 | 5 | PF02210 | |
| Domain | - | ANKS1B ARHGEF11 MTMR10 ASAP2 PLCG1 PLCG2 ROCK2 CDC42BPA APBA1 EPB41L5 CIT RGS12 OPHN1 ARHGEF40 FARP1 PHLDB2 PLCE1 | 8.48e-04 | 391 | 339 | 17 | 2.30.29.30 |
| Domain | C2 | 9.01e-04 | 137 | 339 | 9 | SM00239 | |
| Domain | RasGAP_C | 9.74e-04 | 3 | 339 | 2 | IPR000593 | |
| Domain | RasGAP_C | 9.74e-04 | 3 | 339 | 2 | PF03836 | |
| Domain | Serine_rich | 9.74e-04 | 3 | 339 | 2 | IPR014928 | |
| Domain | SSDP_DNA-bd | 9.74e-04 | 3 | 339 | 2 | IPR008116 | |
| Domain | Serine_rich | 9.74e-04 | 3 | 339 | 2 | PF08824 | |
| Domain | - | 9.98e-04 | 25 | 339 | 4 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 9.98e-04 | 25 | 339 | 4 | IPR017946 | |
| Domain | - | SNHG28 PDGFRA FGFRL1 HEPACAM2 PTPRB PTPRF VSTM5 KIR2DL2 CD200 NRCAM ABI3BP TNC MPZL1 BTLA LEPR IFNAR1 TGM4 LRRN3 CD80 EPHA2 OSMR SLAMF7 BTNL9 EPB42 | 1.10e-03 | 663 | 339 | 24 | 2.60.40.10 |
| Domain | Rho_GTPase_activation_prot | 1.10e-03 | 88 | 339 | 7 | IPR008936 | |
| Domain | C2 | 1.16e-03 | 142 | 339 | 9 | PS50004 | |
| Domain | LamG | 1.16e-03 | 44 | 339 | 5 | SM00282 | |
| Domain | HECT | 1.35e-03 | 27 | 339 | 4 | PF00632 | |
| Domain | HECTc | 1.35e-03 | 27 | 339 | 4 | SM00119 | |
| Domain | HECT_dom | 1.35e-03 | 27 | 339 | 4 | IPR000569 | |
| Domain | HECT | 1.35e-03 | 27 | 339 | 4 | PS50237 | |
| Pathway | WP_GPR40_PATHWAY | 4.55e-06 | 15 | 252 | 5 | M39526 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KNTC1 IQGAP2 CENPE ACTC1 ACTN1 ARHGEF11 IQGAP1 ARHGAP31 PIK3CA ARHGAP29 TJP2 KIF2A SFN ROCK2 CDC42BPA DSG2 RBBP6 WWP2 GPS1 OCRL CIT SYDE1 MFN1 OPHN1 ARPC2 ARHGEF40 FARP1 EPHA2 CDC25C SPEN PLIN3 | 5.10e-06 | 720 | 252 | 31 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KNTC1 IQGAP2 CENPE ACTC1 ACTN1 ARHGEF11 IQGAP1 ARHGAP31 PIK3CA ARHGAP29 TJP2 KIF2A SFN ROCK2 CDC42BPA DSG2 RBBP6 WWP2 GPS1 OCRL SYDE1 MFN1 OPHN1 ARPC2 FARP1 EPHA2 CDC25C SPEN PLIN3 | 5.18e-06 | 649 | 252 | 29 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | IQGAP2 ACTC1 ACTN1 ARHGEF11 IQGAP1 ARHGAP31 PIK3CA ARHGAP29 TJP2 ROCK2 CDC42BPA DSG2 RBBP6 WWP2 GPS1 OCRL CIT SYDE1 OPHN1 ARHGEF40 FARP1 EPHA2 SPEN | 6.13e-06 | 450 | 252 | 23 | M27078 |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 6.52e-06 | 16 | 252 | 5 | M40060 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.23e-06 | 57 | 252 | 8 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.26e-06 | 58 | 252 | 8 | M2049 | |
| Pathway | PID_FAK_PATHWAY | 9.41e-06 | 59 | 252 | 8 | M281 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.58e-05 | 46 | 252 | 7 | M48317 | |
| Pathway | BIOCARTA_CXCR4_PATHWAY | 1.66e-05 | 19 | 252 | 5 | MM1375 | |
| Pathway | BIOCARTA_CXCR4_PATHWAY | 1.66e-05 | 19 | 252 | 5 | M882 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 2.43e-05 | 49 | 252 | 7 | M40046 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.46e-05 | 87 | 252 | 9 | M27617 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | IQGAP2 ACTC1 ACTN1 ARHGEF11 IQGAP1 ARHGAP31 PIK3CA ARHGAP29 TJP2 ROCK2 CDC42BPA DSG2 RBBP6 WWP2 GPS1 OCRL SYDE1 OPHN1 FARP1 EPHA2 SPEN | 4.19e-05 | 439 | 252 | 21 | MM15595 |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 4.64e-05 | 54 | 252 | 7 | M3896 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 5.90e-05 | 56 | 252 | 7 | M27616 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ACTC1 ARHGEF11 IQGAP1 ARHGAP31 ARHGAP29 TJP2 ROCK2 CIT OPHN1 ARHGEF40 FARP1 | 7.53e-05 | 149 | 252 | 11 | M41805 |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 8.49e-05 | 26 | 252 | 5 | M27053 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.03e-04 | 27 | 252 | 5 | MM14712 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | ACTA1 ACTA2 ACTC1 ADCY9 RYR2 ITPR3 PLCG1 PLCG2 GNAQ SFN SLC8A1 | 1.14e-04 | 156 | 252 | 11 | M39475 |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.23e-04 | 28 | 252 | 5 | MM14711 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.47e-04 | 29 | 252 | 5 | M779 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.01e-04 | 48 | 252 | 6 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.01e-04 | 48 | 252 | 6 | MM14589 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 2.76e-04 | 33 | 252 | 5 | M39745 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 3.13e-04 | 19 | 252 | 4 | M47596 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.48e-04 | 74 | 252 | 7 | M41807 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.48e-04 | 74 | 252 | 7 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.48e-04 | 74 | 252 | 7 | M39462 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 3.67e-04 | 35 | 252 | 5 | M41738 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 4.11e-04 | 76 | 252 | 7 | M9052 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 4.38e-04 | 9 | 252 | 3 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 4.38e-04 | 9 | 252 | 3 | MM1551 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 4.50e-04 | 154 | 252 | 10 | MM15974 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 4.70e-04 | 21 | 252 | 4 | M47542 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | IQGAP2 ARHGEF11 IQGAP1 ARHGAP31 PIK3CA ARHGAP29 CDC42BPA CIT OPHN1 FARP1 EPHA2 | 4.77e-04 | 184 | 252 | 11 | M41809 |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 4.79e-04 | 37 | 252 | 5 | MM15683 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | PDGFRA PSMC2 ADCY9 ITPR3 PIK3CA FOXO4 PLCG1 MOV10 LAMTOR2 ATN1 WWP2 RICTOR MTA1 CD80 TNKS | 5.21e-04 | 313 | 252 | 15 | M27867 |
| Pathway | WP_G13_SIGNALING | 5.44e-04 | 38 | 252 | 5 | M39606 | |
| Pathway | PID_PDGFRA_PATHWAY | 5.66e-04 | 22 | 252 | 4 | M206 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 6.15e-04 | 39 | 252 | 5 | MM15898 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 6.17e-04 | 10 | 252 | 3 | M47661 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 6.76e-04 | 23 | 252 | 4 | M41817 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.76e-04 | 23 | 252 | 4 | M47676 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 6.92e-04 | 40 | 252 | 5 | M41 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 7.02e-04 | 83 | 252 | 7 | M8728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.38e-04 | 11 | 252 | 3 | M49033 | |
| Pathway | KEGG_FOCAL_ADHESION | PDGFRA ACTN1 PIK3CA ROCK2 COL5A1 COL6A6 TNC BIRC3 BCAR1 CRK THBS4 | 9.16e-04 | 199 | 252 | 11 | M7253 |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 9.38e-04 | 25 | 252 | 4 | MM15608 | |
| Pubmed | KNTC1 IQGAP2 ACTA1 ACTA2 ANKS1B ACTC1 MCM5 ZNF318 ACTN1 RYR2 FER1L6 IQGAP1 NUP205 IVD PHEX STXBP1 SACS DDX23 CC2D2A DLG3 BOD1L1 CHD6 BSN SFN ROCK2 CUX2 ABI3BP PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 GPS1 DBNL AHCYL2 HEATR1 ZFC3H1 ARPC2 ZC3H7A MACF1 UGGT2 ATM ATP12A SEPTIN10 SPAG17 SPEN BTNL9 CFAP46 | 2.08e-14 | 1442 | 348 | 50 | 35575683 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | FAT2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 1.51e-10 | 72 | 348 | 11 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | CDHR5 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 2.05e-10 | 74 | 348 | 11 | 10817752 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EMC4 DNAJA2 PSMC2 EXT1 PTDSS2 NEK9 ADCY9 NUP205 PTPRF C5 GNAQ HERC1 ITM2B GPAT4 KYNU PNPLA2 SGCD WWP2 MPZL1 PCDHA4 BTAF1 DICER1 EPHA2 NEMF IPO13 INTS4 MACF1 UGGT2 PACC1 ATM WDFY3 OSMR ATP12A SEPTIN10 PCCB PLIN3 | 2.24e-10 | 1061 | 348 | 36 | 33845483 |
| Pubmed | FAT2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 3.19e-10 | 77 | 348 | 11 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | FAT2 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 4.87e-10 | 80 | 348 | 11 | 10716726 |
| Pubmed | ABCB7 EMC4 MAP2 PDK3 DNAJA2 MPDZ ADCY9 CDKAL1 DMXL1 ITPR3 PNPT1 SACS UBR5 CLPTM1 DHPS DDX23 ITM2B HSPA4 GPAT4 FKBP5 FRAS1 CDC42BPA DSG2 HSDL2 WWP2 POLRMT EPB41L5 RICTOR ACOT1 HEATR1 ZFC3H1 CHORDC1 DICER1 ZC3H7A NOP58 FARP1 EPHA2 MACF1 UGGT2 AKAP11 ATM USP33 HDLBP | 5.18e-10 | 1487 | 348 | 43 | 33957083 | |
| Pubmed | PSMC2 MCM5 ZNF318 ACTN1 LARP4 GDI1 IQGAP1 NUP205 ITPR3 PNPT1 UBR5 TJP2 DDX23 HSPA4 MOV10 COL5A1 POLRMT NSD1 HEATR1 DICER1 NOP58 GEMIN4 ELAVL1 MACF1 ATM SPEN HDLBP | 7.04e-10 | 653 | 348 | 27 | 22586326 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | IQGAP2 FGFRL1 CDHR5 MTMR10 ADCY9 PTPRF ARHGAP31 PIK3CA PLCB1 DLG3 GNAQ ROCK2 CDC42BPA DSG2 MPZL1 SLITRK4 EPB41L5 RICTOR RGS12 GPR107 PIEZO2 FARP1 EPHA2 IPMK PHLDB2 | 8.99e-10 | 569 | 348 | 25 | 30639242 |
| Pubmed | IQGAP2 CENPE DNAJA2 TRPC4 ANKS1B MPDZ ZNF318 LRRTM1 ARHGEF11 GDI1 NEK9 HNRNPK IQGAP1 UBR5 PLCB1 DLG3 KIF2A BSN WNK3 ROCK2 ZEB1 NRCAM NSD1 GRM4 CIT OPA1 ARPC2 FARP1 ELAVL1 MACF1 TNKS WDFY3 PHLDB2 | 1.03e-09 | 963 | 348 | 33 | 28671696 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 1.54e-09 | 68 | 348 | 10 | 11230163 |
| Pubmed | PSMC2 MPDZ ZNF318 ACTN1 NEK9 HNRNPK NSD3 TJP2 BOD1L1 TTC28 DSG2 RBBP6 IFT74 DBNL NSD1 HEATR1 APOE CHORDC1 CRK NOP58 SPEN PLIN3 HTT HDLBP | 2.17e-09 | 549 | 348 | 24 | 38280479 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M PSMC2 MPDZ MCM5 MTMR10 CDKAL1 HNRNPK NUP205 ITPR3 PTPRF UBR5 DHPS TJP2 PLCG1 HSPA4 FKBP5 SFN ROCK2 DSG2 GPS1 POLRMT EPB41L5 HEATR1 DICER1 OPA1 SIL1 EPHA2 FLAD1 GEMIN4 TNKS CDC25C TNPO3 | 5.14e-09 | 974 | 348 | 32 | 28675297 |
| Pubmed | SNPH IQGAP2 MAP2 DNAJA2 ACTA1 ANKS1B LRRTM1 ACTN1 ARHGEF11 GDI1 GFAP HNRNPK IQGAP1 STXBP1 NRXN2 SACS TJP2 DLG3 KIF2A GNAQ FGG PRKAG2 BSN HSPA4 ROCK2 NRCAM TNC DBNL APOE CIT OPA1 OPHN1 ARPC2 THBS4 FARP1 SYNGR1 ELAVL1 MACF1 CACNA2D3 HDLBP | 5.68e-09 | 1431 | 348 | 40 | 37142655 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCB7 EMC4 ARSK EXT1 PTDSS2 NEK9 CDKAL1 HNRNPK DMXL1 PTPRF CLPTM1 KIF2A ITM2B GPAT4 ROCK2 UBR2 COL5A1 FAT4 FRAS1 DSG2 GPS1 MPZL1 SLITRK4 CHORDC1 SELENON SIL1 GPR107 EPHA2 FHOD1 IPO13 UGGT2 PACC1 ATM OSMR PLIN3 HTT | 5.93e-09 | 1201 | 348 | 36 | 35696571 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | ABCB7 UBR5 TARBP1 EPB41L5 RICTOR BTAF1 OPA1 FHOD1 ATM PHLDB2 HTT | 8.37e-09 | 104 | 348 | 11 | 31240132 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | IQGAP2 MAP2 MCM5 HNRNPK SACS BOD1L1 KIF2A PLCG1 ROCK2 MARS2 IFT74 DBNL EPB41L5 HEATR1 MTA1 FARP1 GEMIN4 ELAVL1 MACF1 TNPO3 PLIN3 HDLBP | 8.54e-09 | 498 | 348 | 22 | 36634849 |
| Pubmed | CDK19 ADGRV1 ADCY9 NRXN2 UBR5 PLCB1 CHD6 CUX2 TTC28 DICER1 AATK MACF1 AKAP11 WDFY3 HPS5 | 1.02e-08 | 225 | 348 | 15 | 12168954 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDGFRA MAP2 MAP3K20 MPDZ NEK9 NSD3 TJP2 FOXO4 BOD1L1 KIF2A WNK3 SFN CDC42BPA TTC28 DSG2 KIF26B IFT74 WWP2 DBNL EPB41L5 RICTOR BCAR1 SYDE1 RGS12 MACF1 AKAP11 CDC25C TNPO3 PHLDB2 | 1.62e-08 | 861 | 348 | 29 | 36931259 |
| Pubmed | PDK3 MAP3K20 MPDZ MCM5 ZNF318 ACTN1 ARHGEF11 SQOR TERF2IP NSD3 IQGAP1 DLG3 KIF2A CHD6 ZC3H7B ITM2B MOV10 EEFSEC CDC42BPA DSG2 RBBP6 DBNL PCDHB7 POLRMT NSD1 EPB41L5 RICTOR HEATR1 ZFC3H1 BABAM2 CIT DICER1 ZC3H7A MTA1 FARP1 GEMIN4 MACF1 SPEN IPMK HDLBP | 1.96e-08 | 1497 | 348 | 40 | 31527615 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FGFRL1 MCM5 ARHGEF11 GADD45A ADCY9 NSD3 ITPR3 PTPRF PLCG1 HERC1 ZC3H7B GPAT4 PNPLA2 FRAS1 CDC42BPA UBE3B POLRMT NSD1 BTAF1 LRRK1 REV3L BABAM2 CIT ARSG SIL1 ARHGEF40 AATK TTLL4 WDFY3 SSBP4 SPEN TNPO3 HTT | 2.89e-08 | 1105 | 348 | 33 | 35748872 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | IQGAP2 ANKS1B ACTN1 IQGAP1 ASAP2 STXBP1 SACS UBR5 DLG3 GNAQ NRCAM PPM1E CIT OPA1 MACF1 AKAP11 | 3.06e-08 | 281 | 348 | 16 | 28706196 |
| Pubmed | 3.08e-08 | 92 | 348 | 10 | 20301317 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MAP2 CENPE TOPAZ1 AK9 ARHGEF11 PTPRB HP TJP2 DDX23 KIF2A HERC1 ARMH3 COL6A6 GPS1 SLITRK4 POLRMT APOE OPA1 RGS12 KDM4A ATM | 4.00e-08 | 497 | 348 | 21 | 36774506 |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 4.03e-08 | 34 | 348 | 7 | 22884324 | |
| Pubmed | A2M CDHR5 FREM2 FAT2 PTPRF HP C5 FGG NRCAM DSG2 TNC LEPR ORM1 ORM2 CDH6 | 5.99e-08 | 257 | 348 | 15 | 16335952 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ADGRB1 MTMR10 ADCY9 IQGAP1 STXBP1 PTPRF ARHGAP31 PLCB1 ROCK2 CDC42BPA DSG2 KIF26B WWP2 MPZL1 EPB41L5 RICTOR FARP1 EPHA2 | 6.21e-08 | 377 | 348 | 18 | 38117590 |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | PKD1L1 PRDM1 FREM2 CC2D2A DNAH5 ODAD3 FRAS1 IFT74 CCDC39 SLIT3 | 6.90e-08 | 100 | 348 | 10 | 25807483 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHB13 PCDHB7 PCDHA4 | 1.00e-07 | 57 | 348 | 8 | 32633719 |
| Pubmed | DNAJA2 ANKS1B ACTN1 GDI1 MTMR10 GFAP TERF2IP HNRNPK IQGAP1 STXBP1 SACS ENPP5 CHD6 PLCG1 TARBP1 VLDLR SGTB NRCAM TTC28 IFT74 APBA1 ACOT1 ZFC3H1 REV3L APOE CIT MTA1 NEMF MACF1 TNKS KDM4A ATM WDFY3 PCCB USP33 | 1.02e-07 | 1285 | 348 | 35 | 35914814 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EMC4 DNAJA2 PSMC2 PTDSS2 CDKAL1 IQGAP1 NUP205 ITPR3 PTPRF UBR5 CLPTM1 ITM2B HSPA4 TARBP1 WNK3 DSG2 HSDL2 IFT74 GPS1 BTAF1 HEATR1 OCRL OPA1 ARHGEF40 EPHA2 GEMIN4 UGGT2 TNPO3 HDLBP | 1.11e-07 | 942 | 348 | 29 | 31073040 |
| Pubmed | GGA2 ADGRV1 ADCY9 IQGAP1 NUP205 NRXN2 ARHGAP31 PLCB1 CEP126 BSN ZC3H7B CDC42BPA LRRK1 DICER1 GPR107 TTLL4 SLIT3 IPO13 AKAP11 KDM4A HPS5 | 1.14e-07 | 529 | 348 | 21 | 14621295 | |
| Pubmed | SNPH CDK19 UBR5 DLG3 BOD1L1 CHD6 ANKRD12 UBR2 FRAS1 NRCAM TTC28 PPM1E AHCYL2 OPA1 MACF1 SPEN USP33 PLCE1 | 1.94e-07 | 407 | 348 | 18 | 12693553 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ZNF143 IQGAP2 GDAP2 PTDSS2 SSBP2 ACTN1 EIPR1 GDI1 NEK9 IQGAP1 NUP205 TTC8 ASAP2 CLPTM1 PTPRQ DHPS KIF3C MOV10 ROCK2 HSDL2 IFT74 UBE3B GPS1 HEATR1 OCRL CHORDC1 DICER1 OPA1 SYDE1 IPO13 UGGT2 CDC25C PRAME TNPO3 PHLDB2 | 1.96e-07 | 1321 | 348 | 35 | 27173435 |
| Pubmed | A2M ZNF143 MPDZ FREM2 KIF2A ZC3H7B KYNU EEFSEC FRAS1 ATN1 TTC28 UBE3B POLRMT RICTOR BTAF1 DICER1 SYDE1 ARHGEF40 NEMF UGGT2 HPS5 USP33 PLCE1 | 2.20e-07 | 650 | 348 | 23 | 38777146 | |
| Pubmed | TRPC4 ANKS1B FGFRL1 EXT1 ADGRV1 SQOR CDKAL1 RYR2 TTC8 CDH20 CC2D2A ATP8B3 UBR2 RBBP6 SGCD XDH RICTOR C16orf96 ARPC2 SLC8A1 AATK FARP1 OSMR ATP12A SPAG17 IPMK | 2.56e-07 | 814 | 348 | 26 | 23251661 | |
| Pubmed | 2.64e-07 | 44 | 348 | 7 | 19029045 | ||
| Pubmed | 2.70e-07 | 15 | 348 | 5 | 23515096 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.01e-07 | 28 | 348 | 6 | 15347688 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | TOPAZ1 MTMR10 HNRNPK PTPRB ARHGAP29 CHD6 HERC1 TNC PCDHGA3 BTAF1 LRRK1 GRM4 SLC45A4 STPG4 AATK EPHA2 CDC25C SPEN | 3.07e-07 | 420 | 348 | 18 | 28065597 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KNTC1 MAP2 DNAJA2 ACTA2 PSMC2 ACTC1 ACTN1 GDI1 SQOR GFAP NUP205 STXBP1 CC2D2A HSPA4 SFN UBE3B DBNL EPB41L5 EPHA2 FHOD1 GEMIN4 | 3.27e-07 | 564 | 348 | 21 | 21565611 |
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 3.37e-07 | 7 | 348 | 4 | 9384381 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA4 DNAJA2 MAP3K20 PSMC2 MCM5 ACTN1 LARP4 NEK9 HNRNPK IQGAP1 NUP205 UBR5 DDX23 KIF2A PLCG1 PLCG2 HSPA4 MOV10 DBNL POLRMT EPB41L5 RICTOR HEATR1 OCRL ZC3H7A NOP58 ARHGEF40 FHOD1 ZBTB10 GEMIN4 ELAVL1 MACF1 WDFY3 PHLDB2 HDLBP | 3.44e-07 | 1353 | 348 | 35 | 29467282 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DNAJA2 ACTA2 LARP4 HNRNPK TJP2 MOV10 EEFSEC DBNL EPB41L5 C16orf96 OCRL ZFC3H1 DICER1 ARPC2 ZC3H7A NOP58 MTA1 FARP1 EPHA2 MACF1 SPEN PCCB PLIN3 HDLBP | 3.87e-07 | 724 | 348 | 24 | 36232890 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 DNAJA2 MCM5 NEK9 HNRNPK IQGAP1 NUP205 CC2D2A BOD1L1 KIF2A KIF3C PLCG1 TDRD6 BSN ITM2B DNAH5 HSPA4 MARS2 DSG2 HSDL2 DBNL POLRMT BIRC3 NIPSNAP3A HEATR1 CHORDC1 DICER1 OPA1 ARPC2 NOP58 NEMF GEMIN4 ELAVL1 ATM SPEN HDLBP | 4.06e-07 | 1425 | 348 | 36 | 30948266 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ABCB7 EMC4 CENPE PDK2 PDK3 DNAJA2 PSMC2 LARP4 ADCY9 CDKAL1 HNRNPK ITPR3 IVD MRPS30 PNPT1 KIF2A HERC1 GPAT4 MOV10 ATN1 APOO TTC28 HSDL2 POLRMT ACOT1 AHCYL2 HEATR1 OCRL OPA1 MFN1 NOP58 FLAD1 GEMIN4 ELAVL1 AKAP11 PRAME USP33 | 4.63e-07 | 1496 | 348 | 37 | 32877691 |
| Pubmed | 5.46e-07 | 17 | 348 | 5 | 8997639 | ||
| Pubmed | DNAJA2 ACTA1 PSMC2 ACTN1 HNRNPK IQGAP1 PIK3CA SFN CASS4 LRRK1 BCAR1 BABAM2 CRK PCCB | 5.79e-07 | 266 | 348 | 14 | 19380743 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACTA1 ACTC1 MCM5 ZNF318 ACTN1 HNRNPK IQGAP1 NUP205 ITPR3 PTPRF SACS UBR5 TJP2 DDX23 KIF2A HSPA4 DSG2 MPZL1 BTAF1 HEATR1 CIT DICER1 ARPC2 NOP58 ELAVL1 MACF1 SPEN PHLDB2 HDLBP | 6.14e-07 | 1024 | 348 | 29 | 24711643 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABCB7 GGA2 CENPE DNAJA2 PKD1L1 PSMC2 MCM5 ARHGEF11 IQGAP1 NUP205 UBR5 ARHGAP29 TJP2 CZIB TTC28 DSG2 IFT74 DBNL OCRL CHORDC1 RGS12 ARPC2 ZC3H7A FARP1 PCCB PDZRN3 | 6.18e-07 | 853 | 348 | 26 | 28718761 |
| Pubmed | PDK3 DNAJA2 ACTA2 PSMC2 MPDZ MCM5 ACTN1 LARP4 GDI1 GFAP TERF2IP HNRNPK IQGAP1 NUP205 MRPS30 UBR5 DHPS KIF2A HSPA4 FKBP5 MOV10 HSDL2 IFT74 GPS1 POLRMT DICER1 OPA1 MTA1 FLAD1 ZBTB10 ELAVL1 PCCB TNPO3 HDLBP | 7.26e-07 | 1335 | 348 | 34 | 29229926 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | DNAJA2 ACTN1 RYR2 IVD TDRD6 HSPA4 EEFSEC ATN1 REV3L CFAP58 MACF1 TNKS | 8.08e-07 | 197 | 348 | 12 | 20811636 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | MAGEA4 MCM5 LARP4 NUP205 ZC3H7B HSPA4 MOV10 SFN CHORDC1 CIT ZC3H7A NOP58 ELAVL1 MACF1 PHLDB2 | 8.14e-07 | 315 | 348 | 15 | 26777405 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 IQGAP2 CDK19 PSMC2 MCM5 EXT1 EIPR1 GDI1 NEK9 IQGAP1 NUP205 MLKL TTBK2 ASAP2 UBR5 DHPS TJP2 DDX23 DLG3 HERC1 MOV10 ROCK2 GPS1 DBNL HEATR1 LRRK1 BABAM2 OPA1 ARPC2 GEMIN4 AKAP11 TNPO3 HDLBP | 8.75e-07 | 1284 | 348 | 33 | 17353931 |
| Pubmed | PSMC2 MPDZ ADCY9 CDKAL1 HNRNPK IQGAP1 ARHGAP29 BOD1L1 HSPA4 ROCK2 CDC42BPA TTC28 DSG2 EPB41L5 RICTOR OCRL OPA1 CRK EPHA2 GEMIN4 MACF1 PLIN3 HDLBP | 9.59e-07 | 708 | 348 | 23 | 39231216 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 9.93e-07 | 3 | 348 | 3 | 7780165 | |
| Pubmed | 9.93e-07 | 3 | 348 | 3 | 9510033 | ||
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 1.01e-06 | 19 | 348 | 5 | 18316483 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP2 TSHZ2 CDK19 FGFRL1 ADGRV1 EIPR1 LARP4 GRHL2 NEK9 TERF2IP TTC8 ASAP2 PTPRB ENPP5 BOD1L1 CHD6 ANKRD12 PLCG1 PRKAG2 FKBP5 UBR2 COL5A1 CDC42BPA WWP2 AFF3 BTAF1 AHCYL2 BCAR1 SELENON BABAM2 SIL1 FARP1 NEMF MACF1 HPS5 HTT | 1.13e-06 | 1489 | 348 | 36 | 28611215 |
| Pubmed | DNAJA2 ZNF318 SQOR ADCY9 CDKAL1 NSD3 MLKL UBR5 DHPS VLDLR ATN1 TTC28 DSG2 RNASEH2A RBBP6 POLRMT RICTOR C16orf96 REV3L DICER1 OPA1 ARHGEF40 MTA1 ARHGEF33 ZBTB10 MACF1 WDFY3 OSMR PDZRN3 PHLDB2 | 1.14e-06 | 1116 | 348 | 30 | 31753913 | |
| Pubmed | 1.19e-06 | 9 | 348 | 4 | 10501179 | ||
| Pubmed | 1.19e-06 | 9 | 348 | 4 | 7589147 | ||
| Pubmed | 1.34e-06 | 20 | 348 | 5 | 23791195 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M MAGEA4 DNAJA2 MAP3K20 ACTC1 MCM5 ACTN1 GDI1 SQOR HNRNPK NSD3 IQGAP1 NUP205 ITPR3 TJP2 KIF2A MOV10 SFN DSG2 RBBP6 POLRMT HEATR1 ZFC3H1 CIT ARPC2 NOP58 FHOD1 GEMIN4 ELAVL1 SPEN PHLDB2 HDLBP | 1.58e-06 | 1257 | 348 | 32 | 36526897 |
| Pubmed | EMC4 MAP2 PDK2 PDK3 DNAJA2 ADGRB1 ANKS1B PSMC2 GFAP RYR2 STXBP1 PLCB1 TJP2 DLG3 KIF2A BSN CDC42BPA NRCAM DBNL APBA1 RICTOR AHCYL2 CIT OPA1 FARP1 SYNGR1 MACF1 SEPTIN10 PCCB HDLBP | 1.72e-06 | 1139 | 348 | 30 | 36417873 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 MAP2 ACTA1 PSMC2 MCM5 ACTN1 POLA2 GDI1 NEK9 TERF2IP HNRNPK IQGAP1 NUP205 DHPS TJP2 PLCG1 HERC1 HSPA4 KYNU FKBP5 SFN ROCK2 RNASEH2A GPS1 DBNL BCAR1 CHORDC1 BABAM2 ARPC2 MACF1 SEPTIN10 TNPO3 PLIN3 HTT HDLBP | 1.80e-06 | 1455 | 348 | 35 | 22863883 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.83e-06 | 58 | 348 | 7 | 30377227 | |
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 1.97e-06 | 10 | 348 | 4 | 1991513 | |
| Pubmed | ABCB7 PDK3 DNAJA2 NEK9 CDKAL1 IVD MRPS30 PNPT1 CLPTM1 DLG3 PLCG1 ITM2B GPAT4 MARS2 HSDL2 EPB41L5 ACOT1 DICER1 FHOD1 FLAD1 AKAP11 TNPO3 | 2.04e-06 | 686 | 348 | 22 | 28380382 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | DNAJA2 EIPR1 ARHGEF11 GDI1 HNRNPK IQGAP1 MLKL PLCG1 PLCG2 HSPA4 MOV10 XDH ARPC2 ELAVL1 HTT | 2.42e-06 | 344 | 348 | 15 | 30333137 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | ACTA1 ZNF318 UBR5 ARHGAP31 ARHGAP29 ANKRD12 RBBP6 ZNF746 SPEN PCCB PHLDB2 | 2.79e-06 | 184 | 348 | 11 | 32908313 |
| Pubmed | 2.83e-06 | 23 | 348 | 5 | 9278385 | ||
| Pubmed | 2.83e-06 | 23 | 348 | 5 | 9730685 | ||
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 3.08e-06 | 11 | 348 | 4 | 19639585 | |
| Pubmed | MCM5 LARP4 NEK9 HNRNPK PNPT1 DDX23 KIF2A PLCG1 BSN MOV10 ROCK2 FRAS1 RBBP6 GPS1 BTAF1 OPA1 MFN1 NOP58 NEMF ELAVL1 TNPO3 | 3.35e-06 | 653 | 348 | 21 | 33742100 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | UPB1 PDK3 ADGRB1 ANKS1B NEK9 ADCY9 CDKAL1 PNPT1 USP42 DHPS CC2D2A DLG3 HERC1 ARMH3 APOO UBE3B AFF3 SLITRK4 ACOT1 APOE SELENON CIT ARSG GPR107 ARPC2 IFNAR1 MTA1 TTLL4 APOL4 SEPTIN10 USP33 | 3.46e-06 | 1242 | 348 | 31 | 30973865 |
| Pubmed | 3.54e-06 | 24 | 348 | 5 | 10843712 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.58e-06 | 120 | 348 | 9 | 31413325 | |
| Pubmed | DNAJA2 PSMC2 MCM5 GDI1 HNRNPK IQGAP1 ITPR3 PNPT1 PIK3CA DHPS KIF2A HSPA4 FKBP5 SFN ROCK2 UBR2 CDC42BPA ATN1 RBBP6 WWP2 APOE CIT OPA1 ARPC2 NOP58 EPHA2 NEMF ELAVL1 PLIN3 PHLDB2 HDLBP | 3.75e-06 | 1247 | 348 | 31 | 27684187 | |
| Pubmed | KNTC1 ABCB7 IQGAP2 DNAJA2 ACTA2 PSMC2 IRF2 AK6 MCM5 SSBP2 CDKAL1 IQGAP1 NUP205 ITPR3 UBR5 TJP2 DDX23 HSPA4 FKBP5 MOV10 COL5A1 POLRMT BTAF1 HEATR1 DICER1 ARPC2 NOP58 GEMIN4 IPO13 ELAVL1 ATM SSBP4 TNPO3 PLIN3 | 3.81e-06 | 1440 | 348 | 34 | 30833792 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | IQGAP2 FGFRL1 MCM5 SQOR PTPRF BOD1L1 DSG2 RBBP6 WWP2 MTA1 EPHA2 GEMIN4 ATM SPEN | 3.91e-06 | 313 | 348 | 14 | 38270169 |
| Pubmed | DNAJA2 ACTC1 MCM5 ACTN1 ARHGEF11 IQGAP1 NUP205 ITPR3 DDX23 KIF2A DSG2 HEATR1 CIT ARPC2 NOP58 FARP1 EPHA2 ELAVL1 MACF1 SEPTIN10 PHLDB2 | 3.94e-06 | 660 | 348 | 21 | 32780723 | |
| Pubmed | 3.94e-06 | 4 | 348 | 3 | 7774933 | ||
| Pubmed | 3.94e-06 | 4 | 348 | 3 | 12752375 | ||
| Pubmed | 3.94e-06 | 4 | 348 | 3 | 33756341 | ||
| Pubmed | 3.94e-06 | 4 | 348 | 3 | 27207522 | ||
| Pubmed | ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade. | 3.94e-06 | 4 | 348 | 3 | 21875593 | |
| Pubmed | 3.94e-06 | 4 | 348 | 3 | 7682895 | ||
| Pubmed | 3.94e-06 | 4 | 348 | 3 | 15656993 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SLC6A17 MRPS30 UBR5 CLPTM1 ABCD4 HERC1 TARBP1 VLDLR CDC42BPA DSG2 MPZL1 EPB41L5 RICTOR ACOT1 BTAF1 AIDA OCRL RGS12 FHOD1 FLAD1 MACF1 SLAMF7 | 4.33e-06 | 719 | 348 | 22 | 35337019 |
| Pubmed | 4.58e-06 | 12 | 348 | 4 | 30980466 | ||
| Pubmed | 4.58e-06 | 12 | 348 | 4 | 9183385 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | A2M ZNF143 CENPE TSHZ2 LARP4 MTMR10 DLG3 CHD6 CD200 TNC LEPR FARP1 GPN2 CDH6 USP33 | 4.64e-06 | 363 | 348 | 15 | 14691545 |
| Pubmed | ABCB7 PDGFRA DNAJA2 ACTA1 ACTA2 ADGRB1 ACTC1 MCM5 FGG FAT4 FRAS1 NRCAM TTC28 EPB41L5 MFN1 ELAVL1 OSMR SPAG17 | 5.20e-06 | 513 | 348 | 18 | 25798074 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MAP2 DNAJA2 PSMC2 ACTN1 GFAP HNRNPK ASAP2 STXBP1 KIF2A GNAQ TDRD6 BSN SFN ROCK2 BCAR1 OPA1 SYNGR1 ATP12A HTT HDLBP | 5.61e-06 | 621 | 348 | 20 | 22794259 |
| Pubmed | 5.96e-06 | 162 | 348 | 10 | 15174051 | ||
| Pubmed | ADCY9 CDKAL1 STXBP1 PIK3CA PLCB1 DLG3 ROCK2 DSG2 MPZL1 EPB41L5 RICTOR OCRL OPA1 EPHA2 MACF1 PHLDB2 | 6.47e-06 | 421 | 348 | 16 | 36976175 | |
| Pubmed | ZNF318 CDKAL1 MRPS30 ZC3H7B MOV10 DSG2 RNASEH2A POLRMT NSD1 DICER1 GEMIN4 AKAP11 | 6.82e-06 | 242 | 348 | 12 | 34011540 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | A2M SNPH MPDZ HNRNPK DMXL1 IQGAP1 PLCB1 CHD6 HSPA4 SFN HSDL2 OPHN1 NEMF ELAVL1 TNKS HTT HDLBP | 7.35e-06 | 475 | 348 | 17 | 31040226 |
| Pubmed | SQOR ITPR3 IVD UBR5 PIK3CA DHPS HSPA4 FKBP5 UBR2 TTC28 DSG2 GPS1 POLRMT BABAM2 ELAVL1 MACF1 SEPTIN10 TNPO3 PLIN3 HDLBP | 7.60e-06 | 634 | 348 | 20 | 34591612 | |
| Interaction | RAC1 interactions | IQGAP2 DNAJA2 ACTA1 PSMC2 ACTC1 POLA2 ARHGEF11 MTMR10 ADCY9 HNRNPK IQGAP1 NUP205 PTPRF ARHGAP31 PIK3CA ROCK2 CDC42BPA DSG2 KIF26B WWP2 UBE3B MPZL1 SLITRK4 EPB41L5 BIRC3 RICTOR AHCYL2 OCRL BCAR1 AKIP1 CIT SYDE1 OPHN1 ARHGEF40 FARP1 EPHA2 FHOD1 MACF1 OSMR SEPTIN10 PHLDB2 HTT HDLBP | 9.93e-08 | 1063 | 340 | 43 | int:RAC1 |
| Interaction | RHOA interactions | ABCB7 EMC4 ACTA2 ANKS1B ACTC1 AK9 ARHGEF11 ADCY9 CDKAL1 IQGAP1 NUP205 ITPR3 PTPRF ARHGAP31 ARHGAP29 TJP2 DLG3 PLCG1 GPAT4 ROCK2 FAT4 LAMTOR2 CDC42BPA DSG2 HSDL2 WWP2 MPZL1 SLITRK4 POLRMT EPB41L5 BIRC3 RICTOR ACOT1 HEATR1 CIT OPA1 OPHN1 FARP1 EPHA2 GEMIN4 MACF1 PLIN3 PHLDB2 USP33 HTT | 4.08e-07 | 1199 | 340 | 45 | int:RHOA |
| Interaction | C2CD4B interactions | 6.31e-07 | 44 | 340 | 8 | int:C2CD4B | |
| Interaction | RAC3 interactions | IQGAP2 ADCY9 CDKAL1 HNRNPK IQGAP1 PTPRF PIK3CA DLG3 ITM2B GPAT4 ROCK2 FAT4 CDC42BPA DSG2 KIF26B WWP2 MPZL1 SLITRK4 EPB41L5 RICTOR OCRL SYDE1 ARHGEF40 FARP1 EPHA2 FHOD1 MACF1 OSMR PHLDB2 | 7.90e-07 | 619 | 340 | 29 | int:RAC3 |
| Interaction | C11orf52 interactions | IQGAP2 DNAJA2 MPDZ ADCY9 IQGAP1 PTPRF PLCB1 DLG3 CDC42BPA DSG2 MPZL1 EPB41L5 RICTOR AHCYL2 LRRK1 FARP1 EPHA2 MACF1 PHLDB2 | 1.56e-06 | 311 | 340 | 19 | int:C11orf52 |
| Interaction | P2RY8 interactions | PTDSS2 GFAP CDKAL1 NUP205 GNAQ GPAT4 BTAF1 HEATR1 GEMIN4 IPO13 ATM ATP12A PRAME TNPO3 | 2.23e-06 | 179 | 340 | 14 | int:P2RY8 |
| Interaction | RHOB interactions | ABCB7 IQGAP2 ACTA1 ACTC1 ARHGEF11 ADCY9 IQGAP1 NUP205 PTPRF ARHGAP29 PLCB1 TJP2 DLG3 HERC1 ROCK2 UBR2 FAT4 CDC42BPA DSG2 KIF26B WWP2 MPZL1 SLITRK4 EPB41L5 RICTOR AHCYL2 OCRL CIT OPA1 FARP1 EPHA2 ELAVL1 MACF1 PHLDB2 | 2.37e-06 | 840 | 340 | 34 | int:RHOB |
| Interaction | SCGB1D1 interactions | 2.71e-06 | 133 | 340 | 12 | int:SCGB1D1 | |
| Interaction | RHOF interactions | ABCB7 ACTA2 MPDZ MCM5 ACTN1 ADCY9 IQGAP1 NUP205 PTPRF GPAT4 MOV10 ROCK2 FAT4 CDC42BPA DSG2 KIF26B WWP2 MPZL1 SLITRK4 EPB41L5 RICTOR AHCYL2 SYDE1 FARP1 EPHA2 ELAVL1 MACF1 SEPTIN10 HTT | 4.13e-06 | 673 | 340 | 29 | int:RHOF |
| Interaction | RND3 interactions | ACTA2 ACTN1 ADCY9 PTPRF SFN ROCK2 CDC42BPA DSG2 SLITRK4 EPB41L5 RICTOR AHCYL2 HEATR1 CIT FARP1 EPHA2 FHOD1 | 4.32e-06 | 273 | 340 | 17 | int:RND3 |
| Interaction | CDC42 interactions | A2M ABCB7 EMC4 IQGAP2 MAP3K20 ARHGEF11 GDI1 ADCY9 CDKAL1 IQGAP1 NUP205 ITPR3 PTPRF ARHGAP31 ARHGAP29 PLCG2 GPAT4 KYNU ROCK2 FAT4 LAMTOR2 CDC42BPA DSG2 KIF26B WWP2 MPZL1 SLITRK4 EPB41L5 BIRC3 RICTOR AHCYL2 HEATR1 OCRL BCAR1 CIT SYDE1 OPHN1 ARPC2 ARHGEF40 FARP1 EPHA2 FHOD1 ELAVL1 SEPTIN10 HDLBP | 5.66e-06 | 1323 | 340 | 45 | int:CDC42 |
| Interaction | RHOC interactions | EMC4 ACTC1 ARHGEF11 ADCY9 CDKAL1 IQGAP1 PTPRF TJP2 GPAT4 ROCK2 FAT4 LAMTOR2 DSG2 WWP2 MPZL1 SLITRK4 EPB41L5 RICTOR CIT FARP1 EPHA2 MACF1 OSMR PHLDB2 USP33 HTT | 7.45e-06 | 584 | 340 | 26 | int:RHOC |
| Interaction | TPM3 interactions | ACTA1 PSMC2 ACTN1 RYR2 IQGAP1 UBR5 PRKAG2 KYNU FKBP5 MOV10 DBNL BIRC3 RICTOR ZFC3H1 APOE CIT OPA1 ELAVL1 HTT HDLBP | 1.16e-05 | 390 | 340 | 20 | int:TPM3 |
| Interaction | CTDP1 interactions | ABCB7 UBR5 FGF12 TARBP1 WWP2 EPB41L5 RICTOR BTAF1 CIT OPA1 FHOD1 ATM PHLDB2 HTT | 1.20e-05 | 207 | 340 | 14 | int:CTDP1 |
| Interaction | TPTE2 interactions | 1.21e-05 | 84 | 340 | 9 | int:TPTE2 | |
| Interaction | LGALS1 interactions | MCM5 CDHR5 HEPACAM2 HNRNPK FREM2 PTPRB FKBP5 ROCK2 FAT4 FRAS1 NRCAM WWP2 CHORDC1 CIT IFNAR1 GEMIN4 SLAMF7 PLIN3 | 1.52e-05 | 332 | 340 | 18 | int:LGALS1 |
| Interaction | TRPC3 interactions | 1.66e-05 | 33 | 340 | 6 | int:TRPC3 | |
| Interaction | GRB2 interactions | A2M PDGFRA MAP2 ACTA1 PSMC2 GFAP HNRNPK IQGAP1 ASAP2 HP PIK3CA PLCG1 PLCG2 ZC3H7B ABI3BP RBBP6 WWP2 GPS1 BTLA LRRK1 OCRL BCAR1 BABAM2 CRK MTA1 EPHA2 FHOD1 ELAVL1 WDFY3 ZMYM6 HTT | 1.84e-05 | 806 | 340 | 31 | int:GRB2 |
| Interaction | SIGLECL1 interactions | KNTC1 ENPP5 ITM2B MPZL1 BTAF1 EPHA2 GEMIN4 IPO13 INTS4 TNPO3 | 2.18e-05 | 113 | 340 | 10 | int:SIGLECL1 |
| Interaction | NPTN interactions | KNTC1 ACTA2 TARBP1 TTC28 BTAF1 HEATR1 APOE OPA1 MFN1 FHOD1 GEMIN4 IPO13 ATM PRAME TNPO3 HTT | 2.20e-05 | 278 | 340 | 16 | int:NPTN |
| Interaction | YWHAH interactions | MAP2 MAP3K20 PSMC2 MPDZ POLA2 MTMR10 HNRNPK NSD3 IQGAP1 PIK3CA TJP2 CC2D2A FOXO4 BOD1L1 KIF2A HERC1 HSPA4 WNK3 SFN CDC42BPA TTC28 DSG2 KIF26B IFT74 DBNL EPB41L5 RICTOR BCAR1 CCDC39 SYDE1 RGS12 CRK ELAVL1 MACF1 AKAP11 CDC25C PHLDB2 HTT | 2.39e-05 | 1102 | 340 | 38 | int:YWHAH |
| Interaction | GPR17 interactions | KNTC1 SACS CLPTM1 TARBP1 BTAF1 HEATR1 OPA1 MFN1 GEMIN4 IPO13 ATM WDFY3 ATP12A TNPO3 USP33 HTT | 2.73e-05 | 283 | 340 | 16 | int:GPR17 |
| Interaction | ARHGEF2 interactions | FREM2 PTPRF PLCG1 MOV10 SFN CDC42BPA APOO WWP2 DBNL RICTOR BCAR1 CIT ELAVL1 HTT HDLBP | 3.22e-05 | 256 | 340 | 15 | int:ARHGEF2 |
| Interaction | FBXO22 interactions | MAP2 CENPE TOPAZ1 AK9 ARHGEF11 PTPRB HP TJP2 DDX23 KIF2A HERC1 ARMH3 COL6A6 GPS1 SLITRK4 POLRMT BCAR1 APOE CIT OPA1 RGS12 KDM4A ATM | 5.00e-05 | 540 | 340 | 23 | int:FBXO22 |
| Interaction | DUSP26 interactions | 5.88e-05 | 59 | 340 | 7 | int:DUSP26 | |
| Interaction | XAGE1A interactions | 6.03e-05 | 41 | 340 | 6 | int:XAGE1A | |
| Interaction | LGALSL interactions | 6.52e-05 | 26 | 340 | 5 | int:LGALSL | |
| Interaction | ADAMTS13 interactions | 6.52e-05 | 26 | 340 | 5 | int:ADAMTS13 | |
| Interaction | NUP43 interactions | DNAJA2 ACTC1 ZNF318 RYR2 NSD3 UBR5 BOD1L1 KIF2A CHD6 ATN1 HSDL2 RBBP6 IFT74 DBNL NSD1 RICTOR HEATR1 ZFC3H1 CIT NOP58 MTA1 ZBTB10 HPS5 SPEN PCCB | 6.53e-05 | 625 | 340 | 25 | int:NUP43 |
| Interaction | RHOQ interactions | IQGAP2 ADCY9 DMXL1 IQGAP1 PTPRF PIK3CA DLG3 ITM2B ROCK2 LAMTOR2 CDC42BPA DSG2 WWP2 SLITRK4 EPB41L5 RICTOR SYDE1 FARP1 EPHA2 ELAVL1 | 6.83e-05 | 442 | 340 | 20 | int:RHOQ |
| Interaction | CASS4 interactions | 6.97e-05 | 14 | 340 | 4 | int:CASS4 | |
| Interaction | KIF23 interactions | DNAJA2 ACTA1 ACTC1 ZNF200 AK9 LARP4 GFAP TERF2IP HNRNPK IQGAP1 ITPR3 UBR5 TJP2 DDX23 MOV10 SFN COL5A1 VLDLR DSG2 NSD1 XDH BIRC3 RICTOR HEATR1 ZFC3H1 CIT OPA1 NOP58 FARP1 GEMIN4 ELAVL1 MACF1 HPS5 PHLDB2 HTT | 6.98e-05 | 1031 | 340 | 35 | int:KIF23 |
| Interaction | TERF2 interactions | DNAJA2 FGFRL1 ACTN1 TERF2IP RYR2 IVD TDRD6 ARMH3 HSPA4 EEFSEC ATN1 REV3L ZBTB10 ELAVL1 MACF1 TNKS ATM | 7.20e-05 | 340 | 340 | 17 | int:TERF2 |
| Interaction | TOP3B interactions | DNAJA2 FGFRL1 MCM5 ACTN1 LARP4 ARHGEF11 GADD45A ADCY9 CDKAL1 NSD3 IQGAP1 ITPR3 PTPRF PLCG1 HERC1 ZC3H7B GPAT4 MOV10 PNPLA2 FRAS1 CDC42BPA UBE3B APBA1 POLRMT NSD1 BTAF1 LRRK1 REV3L BABAM2 CIT ARSG SIL1 ARPC2 ZC3H7A ARHGEF40 AATK TTLL4 ELAVL1 KDM4A WDFY3 SSBP4 SPEN TNPO3 HTT HDLBP | 7.49e-05 | 1470 | 340 | 45 | int:TOP3B |
| Interaction | P2RY10 interactions | 7.78e-05 | 106 | 340 | 9 | int:P2RY10 | |
| Interaction | PRKACA interactions | SNPH MAP2 IRF2 LARP4 GFAP RYR2 IQGAP1 ITPR3 FGG HSPA4 FKBP5 MOV10 PNPLA2 BIRC3 AKIP1 CRK ARPC2 IFNAR1 EPHA2 ELAVL1 AKAP11 HTT | 7.81e-05 | 519 | 340 | 22 | int:PRKACA |
| Interaction | RHOJ interactions | ABCB7 IQGAP2 ADCY9 IQGAP1 NUP205 PTPRF ITM2B ROCK2 CDC42BPA DSG2 WWP2 MPZL1 SLITRK4 POLRMT EPB41L5 RICTOR OCRL SYDE1 FARP1 EPHA2 FHOD1 MACF1 OSMR SEPTIN10 PHLDB2 | 7.99e-05 | 633 | 340 | 25 | int:RHOJ |
| Interaction | RAC2 interactions | ABCB7 GDI1 ADCY9 CDKAL1 IQGAP1 NUP205 ITPR3 PTPRF GPAT4 LAMTOR2 CDC42BPA DSG2 KIF26B WWP2 MPZL1 SLITRK4 EPB41L5 RICTOR SYDE1 ARHGEF40 FARP1 EPHA2 FHOD1 MACF1 PHLDB2 HTT | 8.44e-05 | 674 | 340 | 26 | int:RAC2 |
| Interaction | PRSS37 interactions | 9.38e-05 | 15 | 340 | 4 | int:PRSS37 | |
| Interaction | GCGR interactions | 1.04e-04 | 110 | 340 | 9 | int:GCGR | |
| Interaction | KIF20A interactions | CENPE GDAP2 DNAJA2 ACTC1 MCM5 ZNF318 ACTN1 SQOR GFAP HNRNPK NSD3 NUP205 UBR5 TJP2 BOD1L1 PLCG2 GNAQ HERC1 MOV10 DSG2 HSDL2 RBBP6 POLRMT HEATR1 LRRK1 CIT RGS12 ARPC2 NOP58 PIEZO2 ELAVL1 MACF1 TNKS SEPTIN10 PHLDB2 | 1.04e-04 | 1052 | 340 | 35 | int:KIF20A |
| Interaction | ZBTB46 interactions | 1.13e-04 | 29 | 340 | 5 | int:ZBTB46 | |
| Interaction | CMA1 interactions | 1.17e-04 | 46 | 340 | 6 | int:CMA1 | |
| Interaction | RHOD interactions | EMC4 ACTN1 ADCY9 CDKAL1 IQGAP1 NUP205 ITPR3 PTPRF GPAT4 ROCK2 CDC42BPA DSG2 KIF26B MPZL1 SLITRK4 EPB41L5 RICTOR OCRL ARPC2 FARP1 EPHA2 MACF1 SEPTIN10 | 1.18e-04 | 572 | 340 | 23 | int:RHOD |
| Interaction | NPY2R interactions | 1.21e-04 | 66 | 340 | 7 | int:NPY2R | |
| Interaction | CCP110 interactions | HNRNPK DHDH UBR5 HSPA4 MOV10 SFN CRK ARPC2 ELAVL1 SEPTIN10 USP33 | 1.24e-04 | 166 | 340 | 11 | int:CCP110 |
| Interaction | MLNR interactions | 1.47e-04 | 68 | 340 | 7 | int:MLNR | |
| Interaction | MYO1C interactions | PDGFRA ACTA1 ACTA2 ACTC1 MCM5 LARP4 SQOR IQGAP1 TJP2 WWP2 BIRC3 RICTOR CIT FARP1 EPHA2 ZNF746 CDC25C PHLDB2 | 1.53e-04 | 397 | 340 | 18 | int:MYO1C |
| Interaction | SHC1 interactions | DNAJA2 ACTA1 ANKS1B GFAP IQGAP1 STXBP1 PLCG1 PLCG2 HSPA4 MOV10 SFN WWP2 LRRK1 CRK EPHA2 CDC25C PLIN3 | 1.54e-04 | 362 | 340 | 17 | int:SHC1 |
| Interaction | SETD9 interactions | 1.58e-04 | 7 | 340 | 3 | int:SETD9 | |
| Interaction | ETNPPL interactions | 1.58e-04 | 7 | 340 | 3 | int:ETNPPL | |
| Interaction | ARF6 interactions | GGA2 IQGAP2 DNAJA2 MTMR10 ADCY9 CDKAL1 IQGAP1 ASAP2 PTPRF DHPS PLCB1 TJP2 GNAQ ROCK2 CDC42BPA DSG2 MPZL1 EPB41L5 RICTOR OPA1 FARP1 EPHA2 HTT | 1.60e-04 | 584 | 340 | 23 | int:ARF6 |
| Interaction | SIRT7 interactions | PSMC2 MCM5 ZNF318 ACTN1 LARP4 GDI1 IQGAP1 NUP205 ITPR3 PNPT1 UBR5 TJP2 DDX23 HSPA4 MOV10 COL5A1 POLRMT NSD1 HEATR1 DICER1 NOP58 GEMIN4 ELAVL1 MACF1 ATM SPEN HDLBP | 1.68e-04 | 744 | 340 | 27 | int:SIRT7 |
| Interaction | RHOG interactions | ABCB7 EMC4 IQGAP2 ACTA2 ADCY9 CDKAL1 IQGAP1 ITPR3 MRPS30 PNPT1 PTPRF UBR5 DLG3 GPAT4 ROCK2 LAMTOR2 CDC42BPA DSG2 HSDL2 KIF26B WWP2 MPZL1 SLITRK4 POLRMT EPB41L5 RICTOR ACOT1 FARP1 EPHA2 FLAD1 MACF1 | 1.73e-04 | 910 | 340 | 31 | int:RHOG |
| Interaction | LANCL2 interactions | 1.77e-04 | 93 | 340 | 8 | int:LANCL2 | |
| Interaction | FLOT1 interactions | PDGFRA DNAJA2 MPDZ IQGAP1 BOD1L1 LAMTOR2 CDC42BPA SGTB APOO DSG2 EPB41L5 BIRC3 RICTOR BCAR1 CIT FARP1 EPHA2 MACF1 PHLDB2 HTT | 1.80e-04 | 475 | 340 | 20 | int:FLOT1 |
| Interaction | PDGFA interactions | 1.84e-04 | 32 | 340 | 5 | int:PDGFA | |
| Interaction | PCDHA9 interactions | 1.84e-04 | 32 | 340 | 5 | int:PCDHA9 | |
| Interaction | KCTD13 interactions | SNPH IQGAP2 MAP2 DNAJA2 ACTA1 ANKS1B LRRTM1 ACTN1 ARHGEF11 GDI1 GFAP HNRNPK IQGAP1 STXBP1 NRXN2 SACS TJP2 DLG3 KIF2A GNAQ FGG PRKAG2 BSN HSPA4 ROCK2 NRCAM TNC DBNL AHCYL2 APOE CIT OPA1 CRK OPHN1 ARPC2 THBS4 FARP1 SYNGR1 ELAVL1 MACF1 CACNA2D3 HDLBP | 1.87e-04 | 1394 | 340 | 42 | int:KCTD13 |
| Interaction | CEACAM8 interactions | 1.89e-04 | 119 | 340 | 9 | int:CEACAM8 | |
| Interaction | HCST interactions | TTC8 TARBP1 TTC28 BTAF1 MFN1 GEMIN4 IPO13 ELAVL1 ATM WDFY3 ATP12A TNPO3 | 1.98e-04 | 205 | 340 | 12 | int:HCST |
| Interaction | TAFA5 interactions | 2.02e-04 | 18 | 340 | 4 | int:TAFA5 | |
| Interaction | AGPAT1 interactions | A2M HP TJP2 C5 FGG KYNU MOV10 SFN RNASEH2A DBNL CLIC3 ORM1 ELAVL1 ATP12A | 2.05e-04 | 269 | 340 | 14 | int:AGPAT1 |
| Interaction | SCN2B interactions | 2.05e-04 | 95 | 340 | 8 | int:SCN2B | |
| Interaction | DUSP16 interactions | DNAJA2 ACTA2 PSMC2 EIPR1 POLA2 ROCK2 RNASEH2A RICTOR AKAP11 SEPTIN10 HPS5 PDZRN3 HTT | 2.07e-04 | 237 | 340 | 13 | int:DUSP16 |
| Interaction | SPCS1 interactions | EMC4 ARSK MAP3K20 TJP2 PCDHGA3 BCAR1 ARSG NEMF ATP12A CACNA2D3 | 2.13e-04 | 148 | 340 | 10 | int:SPCS1 |
| Interaction | NXPH2 interactions | 2.14e-04 | 33 | 340 | 5 | int:NXPH2 | |
| Interaction | USP7 interactions | ANKRD31 ZFP42 SNPH CENPE ADGRB1 ACTC1 IRF2 MCM5 FER1L6 IQGAP1 FAT2 FOXO4 KIF2A VSTM5 HERC1 BSN DNAH5 FKBP5 WNK3 SFN ZEB1 CDC42BPA APOO WWP2 NSD1 BIRC3 C16orf96 TEX15 GRM4 BABAM2 DICER1 OPA1 LEPR OPHN1 IFNAR1 CD80 MACF1 BTNL9 TNPO3 PHLDB2 | 2.14e-04 | 1313 | 340 | 40 | int:USP7 |
| Interaction | PAXBP1 interactions | 2.15e-04 | 121 | 340 | 9 | int:PAXBP1 | |
| Interaction | ACTR3 interactions | EMC4 DNAJA2 ACTC1 ACTN1 IQGAP1 STXBP1 DHPS DBNL BIRC3 RICTOR CIT SYDE1 ARPC2 TNPO3 HTT | 2.27e-04 | 305 | 340 | 15 | int:ACTR3 |
| Interaction | OPALIN interactions | KNTC1 ABCB7 NUP205 PTPRF GPAT4 TARBP1 BTAF1 HEATR1 IPO13 ATM WDFY3 TNPO3 | 2.37e-04 | 209 | 340 | 12 | int:OPALIN |
| Interaction | AGAP2 interactions | IQGAP2 ANKS1B ACTN1 IQGAP1 STXBP1 SACS DLG3 PLCG1 GNAQ NRCAM PPM1E MACF1 | 2.48e-04 | 210 | 340 | 12 | int:AGAP2 |
| Interaction | PCDHGA10 interactions | 2.52e-04 | 19 | 340 | 4 | int:PCDHGA10 | |
| Interaction | DCANP1 interactions | 2.52e-04 | 19 | 340 | 4 | int:DCANP1 | |
| Interaction | CCL19 interactions | 2.52e-04 | 19 | 340 | 4 | int:CCL19 | |
| Interaction | CGN interactions | ACTA2 ARHGEF11 MTMR10 IQGAP1 TJP2 SFN SYDE1 CDC25C PHLDB2 HDLBP | 2.65e-04 | 152 | 340 | 10 | int:CGN |
| Interaction | HRAS interactions | ANKRD34B PTPRF USP42 PIK3CA ARHGAP29 PLCB1 DLG3 GNAQ ITM2B MOV10 ROCK2 CDC42BPA TTC28 DSG2 UBE3B MPZL1 EPB41L5 RICTOR RGS12 EPHA2 ZBTB10 CDC25C TNPO3 PHLDB2 PLCE1 HDLBP | 2.67e-04 | 725 | 340 | 26 | int:HRAS |
| Interaction | RYK interactions | ACTA2 FREM2 PTPRF ITM2B MOV10 FAT4 DSG2 PCDHGA11 PCDHGA6 ARPC2 EPHA2 ELAVL1 | 2.70e-04 | 212 | 340 | 12 | int:RYK |
| Interaction | KIT interactions | 2.74e-04 | 125 | 340 | 9 | int:KIT | |
| Interaction | PCDHGB1 interactions | 3.20e-04 | 77 | 340 | 7 | int:PCDHGB1 | |
| Interaction | PPP1CA interactions | CENPE ACTA1 MCM5 NEK9 RYR2 HNRNPK IQGAP1 UBR5 KIF2A CEP126 HSPA4 SFN WWP2 BIRC3 C16orf96 CIT CRK ZC3H7A AATK POLR3E ZBTB10 ELAVL1 AKAP11 ATM HTT | 3.42e-04 | 696 | 340 | 25 | int:PPP1CA |
| Interaction | HYOU1 interactions | ADGRV1 VWDE NUP205 FREM2 CZIB MOV10 FAT4 SGTB APOO BIRC3 RICTOR BCAR1 CCDC39 SIL1 AATK | 3.43e-04 | 317 | 340 | 15 | int:HYOU1 |
| Interaction | FBXO30 interactions | 3.52e-04 | 56 | 340 | 6 | int:FBXO30 | |
| Interaction | NRAS interactions | FGFRL1 MTMR10 CDKAL1 PIK3CA PLCB1 ITM2B ROCK2 CDC42BPA DSG2 HSDL2 MPZL1 SLITRK4 EPB41L5 RICTOR GPR107 PIEZO2 FARP1 EPHA2 FHOD1 ELAVL1 MACF1 PACC1 USP33 PLCE1 HDLBP | 3.64e-04 | 699 | 340 | 25 | int:NRAS |
| Cytoband | 5q31 | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 SIL1 CDC25C | 9.44e-11 | 115 | 349 | 12 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | HSPA4 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 SIL1 RNF14 CDC25C | 8.74e-08 | 298 | 349 | 14 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 PCDHB13 PCDHB7 PCDHA4 | 1.09e-08 | 64 | 239 | 10 | 20 |
| GeneFamily | Actins | 4.43e-05 | 6 | 239 | 3 | 929 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 9.87e-05 | 19 | 239 | 4 | 832 | |
| GeneFamily | Fibronectin type III domain containing | 2.83e-04 | 160 | 239 | 9 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.96e-04 | 181 | 239 | 9 | 694 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.44e-04 | 115 | 239 | 7 | 769 | |
| GeneFamily | Cas scaffolding proteins | 1.03e-03 | 4 | 239 | 2 | 469 | |
| GeneFamily | Cadherin related | 1.35e-03 | 17 | 239 | 3 | 24 | |
| GeneFamily | Phospholipases | 2.25e-03 | 42 | 239 | 4 | 467 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.54e-03 | 21 | 239 | 3 | 813 | |
| GeneFamily | Apolipoproteins | 2.54e-03 | 21 | 239 | 3 | 405 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.14e-03 | 46 | 239 | 4 | 622 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 3.50e-03 | 7 | 239 | 2 | 785 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 2.00e-07 | 86 | 345 | 10 | M39247 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP2 TSHZ2 SLC6A17 ADGRB1 ANKS1B ZNF318 TERF2IP RYR2 FAT2 STXBP1 NRXN2 DLG3 BOD1L1 FGF12 KIF3C ANKRD12 GNAQ CEP126 HERC1 BSN TARBP1 WNK3 COL6A6 AFF3 SLITRK4 APBA1 RICTOR OCRL REV3L GRM4 DICER1 LRRN3 SLC8A1 PIEZO2 AATK TNKS SPAG17 | 2.21e-07 | 1106 | 345 | 37 | M39071 |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | CDK19 IRF2 SSBP2 ZNF318 DMXL1 IQGAP1 CD200 ROCK2 AFF3 RICTOR BTLA AIDA IFNAR1 | 9.03e-07 | 181 | 345 | 13 | M8187 |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | GGA2 CDK19 IRF2 SSBP2 ZNF318 DMXL1 IQGAP1 ABCD4 CD200 AFF3 RICTOR BTLA AIDA | 1.02e-06 | 183 | 345 | 13 | M8189 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPE CDK19 EXT1 SSBP2 LARP4 ADCY9 ASAP2 SACS UBR5 ARHGAP29 TJP2 KIF2A GNAQ ROCK2 UBR2 VLDLR ZEB1 CDC42BPA TTC28 BTAF1 REV3L DICER1 OPA1 MACF1 AKAP11 TNKS WDFY3 OSMR SPEN PLCE1 | 1.29e-06 | 856 | 345 | 30 | M4500 |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP | ZNF200 ST7L NEK9 CZIB CASS4 PCDHGA10 NSD1 AIDA COLEC10 CRK IFNAR1 OSMR | 1.29e-05 | 197 | 345 | 12 | M5020 |
| Coexpression | GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP | IMPG1 CDK19 POLA2 ITPR3 HP GNAQ PPM1E SYDE1 TLR5 COQ7 EPB42 HTT | 1.35e-05 | 198 | 345 | 12 | M8370 |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN | MAGEA4 CDK19 MTMR10 PLCG2 KYNU CD200 SFN FRAS1 TTC28 PCDHGA10 MPZL1 CD80 | 1.35e-05 | 198 | 345 | 12 | M4429 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | ACTA2 EXT1 ACTN1 GADD45A SACS KIF3C COL5A1 FAT4 ZEB1 SGTB AIDA LRRK1 SYDE1 ARHGEF40 EPHA2 ELAVL1 ATM OSMR PHLDB2 | 1.52e-05 | 465 | 345 | 19 | M9192 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | RYR2 TMEM132C FREM2 CDH20 PTPRF PTPRQ ODAD3 ABI3BP PPM1E SLITRK4 CLIC3 GALNT9 SLIT3 CFAP46 PLCE1 | 1.96e-05 | 313 | 345 | 15 | M40228 |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 2.09e-05 | 174 | 345 | 11 | M6850 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | ADCY9 PIK3CA TJP2 DDX23 PLCG1 PRKAG2 ROCK2 HEATR1 OPHN1 NOP58 POLR3E | 3.01e-05 | 181 | 345 | 11 | M6849 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ACTA2 IRF2 NEK9 GADD45A RXRB TERF2IP DMXL1 IQGAP1 SACS UBR5 PIK3CA PRKAG2 HSPA4 FKBP5 UBR2 DSG2 HSDL2 RBBP6 IFT74 CLIC3 BTAF1 OCRL BABAM2 DICER1 OPA1 MFN1 GPR107 RNF14 ZBTB10 ELAVL1 MACF1 KDM4A ATM PLIN3 | 3.16e-05 | 1215 | 345 | 34 | M41122 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | A2M IQGAP1 PTPRB PLCB1 ROCK2 ZEB1 CDC42BPA ABI3BP TTC28 MACF1 | 3.52e-05 | 152 | 345 | 10 | M39243 |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 3.83e-05 | 48 | 345 | 6 | M1568 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.16e-05 | 155 | 345 | 10 | M39246 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 4.32e-05 | 49 | 345 | 6 | MM1178 | |
| Coexpression | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP | 4.92e-05 | 31 | 345 | 5 | M816 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN | UPB1 FAT2 ASAP2 USP42 ANKRD12 EPB41L5 BIRC3 CHORDC1 GPR107 GEMIN4 SLAMF7 | 5.41e-05 | 193 | 345 | 11 | M3137 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP | IQGAP2 TIGD1 EXT1 ST7L ARHGEF11 GADD45A PTPRB TJP2 TARBP1 SGTB TTC28 | 5.67e-05 | 194 | 345 | 11 | M4187 |
| Coexpression | AMIT_EGF_RESPONSE_480_HELA | 6.71e-05 | 164 | 345 | 10 | M8729 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN | 6.71e-05 | 164 | 345 | 10 | M6859 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | CENPE PRDM1 TTBK2 NRXN2 CASS4 UBR2 RICTOR ZFC3H1 ZC3H7A SLAMF7 USP33 | 7.13e-05 | 199 | 345 | 11 | M5970 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | KNTC1 CENPE ARHGEF11 ARHGAP29 KIF3C CDC42BPA RICTOR BCAR1 OPHN1 FARP1 GEMIN4 | 7.13e-05 | 199 | 345 | 11 | M5893 |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN | ABCB7 GGA2 IQGAP2 PTDSS2 MTMR10 PTPRF CC2D2A XDH OPHN1 ZNF746 TNKS | 7.46e-05 | 200 | 345 | 11 | M8651 |
| Coexpression | GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP | MPDZ ACTN1 GFAP STXBP1 TJP2 PLCG2 MPZL1 APOE NMNAT3 ORM1 PHLDB2 | 7.46e-05 | 200 | 345 | 11 | M7506 |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | GGA2 TSHZ2 CDK19 ZNF318 ANKRD12 ZEB1 DICER1 RGS12 NMNAT3 CACNA2D4 POLR3E | 7.46e-05 | 200 | 345 | 11 | M6352 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | GGA2 POLA2 ADCY9 ITPR3 PTPRF ARHGAP29 PLCG2 UBR2 RBBP6 ZFC3H1 DICER1 IPO13 PRAME | 8.32e-05 | 276 | 345 | 13 | M3063 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | ABCB7 PDGFRA MAP2 PTDSS2 GDI1 GRHL2 CDKAL1 TTC8 PTPRF DHPS CZIB HSPA4 CD200 SFN SGTB DSG2 NIPSNAP3A HEATR1 OPHN1 NOP58 WDFY3 OSMR SPEN ZMYM6 | 1.09e-04 | 776 | 345 | 24 | M1107 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | A2M PDGFRA ACTA2 MAP3K20 EXT1 ACTN1 PRDM1 SACS ROCK2 COL5A1 ZEB1 TNC SGCD MPZL1 SYDE1 ARPC2 ARHGEF40 PIEZO2 FARP1 FHOD1 OSMR HDLBP | 1.14e-04 | 681 | 345 | 22 | M39175 |
| Coexpression | GALI_TP53_TARGETS_APOPTOTIC_UP | 1.21e-04 | 8 | 345 | 3 | M16490 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | KANSL1L EXT1 CDKAL1 GNAQ FKBP5 TTC28 BABAM2 FARP1 WDFY3 CDH6 | 1.21e-04 | 176 | 345 | 10 | M39223 |
| Coexpression | MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN | 1.21e-04 | 20 | 345 | 4 | M45042 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 1.42e-04 | 86 | 345 | 7 | M39248 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.45e-04 | 180 | 345 | 10 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | UPB1 ANKS1B AK9 ADGRV1 GADD45A CHD6 PLCG2 PRKAG2 FKBP5 FRAS1 KIF26B ZFC3H1 OPHN1 ZNF804B SLIT3 CFAP46 | 1.47e-04 | 417 | 345 | 16 | M39224 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | ACTN1 PTPRB ARHGAP29 PLCB1 HERC1 ROCK2 ZEB1 RBBP6 ARSG PIEZO2 MACF1 OSMR BTNL9 | 1.61e-04 | 295 | 345 | 13 | M39121 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | PDGFRA MAP2 DNAJA2 PSMC2 GADD45A IVD CHD6 KIF3C CD200 ROCK2 ZEB1 MPZL1 SLIT3 ATP12A HTT | 1.69e-04 | 379 | 345 | 15 | M1885 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_DN | 1.80e-04 | 63 | 345 | 6 | M373 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | ZNF143 IRF2 NEK9 IQGAP1 KIR2DL2 EEFSEC UBR2 SGCD SIL1 IFNAR1 SLC8A1 TLR5 WDFY3 SLAMF7 ZMYM6 HDLBP | 1.88e-04 | 426 | 345 | 16 | M41019 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | PDGFRA MAP2 SSBP2 ZC3H7B FAT4 HSDL2 RBBP6 AFF3 PCDHB7 TEX15 RNF14 PIEZO2 PDZRN3 CACNA2D3 | 1.91e-06 | 188 | 336 | 14 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | PDGFRA MAP2 SSBP2 STXBP1 ANKRD12 FAT4 ABI3BP HSDL2 RBBP6 AFF3 PCDHB7 RNF14 PIEZO2 UGGT2 PDZRN3 CACNA2D3 | 1.56e-05 | 288 | 336 | 16 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | PDGFRA TRPC4 ACTA2 MAP3K20 IRF2 SQOR IQGAP1 MLKL PTPRB STXBP1 ARHGAP31 ENPP5 ANKRD12 ITM2B ROCK2 VLDLR ZEB1 CDC42BPA TTC28 TNC XDH BIRC3 LRRK1 APOE SYDE1 ZC3H7A SLC8A1 PIEZO2 FHOD1 OSMR PHLDB2 | 2.45e-05 | 872 | 336 | 31 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | PDGFRA MAP3K20 NSD3 PHEX TTBK2 PIK3CA KIF2A GNAQ FAT4 ZEB1 RBBP6 AFF3 LEPR UGGT2 TNKS OSMR | 3.40e-05 | 307 | 336 | 16 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | GGA2 SSBP2 GDI1 CDKAL1 NSD3 TMEM132C ARHGAP31 GNAQ AFF3 PCDHB13 SLITRK4 OCRL CIT WDFY3 HTT | 4.55e-05 | 281 | 336 | 15 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | MAP2 CENPE ACTA1 LRRTM1 ADGRV1 LARP4 TTBK2 FREM2 NRXN2 UBR5 BOD1L1 FGF12 KIF2A HSPA4 ROCK2 CUX2 SGTB NRCAM RBBP6 IFT74 PPM1E SLITRK4 EPB41L5 AHCYL2 HEATR1 REV3L BABAM2 CIT DICER1 NOP58 NEMF ZBTB10 IPMK | 4.67e-05 | 989 | 336 | 33 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | PDGFRA IQGAP2 CENPE MAP3K20 MCM5 SSBP2 ADGRV1 NSD3 PHEX TTBK2 PIK3CA KIF2A GNAQ FAT4 ZEB1 RBBP6 AFF3 PCDHB13 EPB41L5 XDH LEPR LRRN3 SLC8A1 PIEZO2 UGGT2 TNKS OSMR CDH6 CACNA2D3 | 4.85e-05 | 819 | 336 | 29 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | GGA2 PDGFRA TSHZ2 ACTA2 SSBP2 GDI1 CDKAL1 NSD3 DMXL1 TMEM132C ARHGAP31 ANKRD12 GNAQ HERC1 COL5A1 VLDLR ABI3BP AFF3 PCDHB13 SLITRK4 AHCYL2 OCRL APOE CIT IFNAR1 SLIT3 WDFY3 HTT | 7.84e-05 | 799 | 336 | 28 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | PDGFRA IQGAP2 MAP2 CENPE TSHZ2 ACTA2 ACTC1 SSBP2 ACTN1 TTC8 CC2D2A FKBP5 WNK3 FRAS1 ZEB1 SGTB ABI3BP TNC KIF26B SGCD AFF3 REV3L LRRN3 SLC8A1 PIEZO2 CDH6 PLCE1 | 1.21e-04 | 777 | 336 | 27 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCB7 CENPE LRRTM1 LARP4 NRXN2 UBR5 FGF12 CHD6 ANKRD12 HSPA4 CD200 FAT4 CDC42BPA SGTB HSDL2 RBBP6 PPM1E SLITRK4 EPB41L5 BTAF1 CIT OPA1 NEMF IPMK | 1.29e-04 | 654 | 336 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPE BOD1L1 KIF2A HSPA4 ROCK2 SGTB RBBP6 IFT74 SLITRK4 REV3L BABAM2 CIT DICER1 NOP58 NEMF | 1.41e-04 | 311 | 336 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | A2M TSHZ2 RYR2 PHEX TMEM132C CASS4 COL5A1 FAT4 FRAS1 ABI3BP COL6A6 TTC28 TNC SGCD PIEZO2 SLIT3 UNC13C PDZRN3 | 1.68e-14 | 193 | 347 | 18 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M SLC6A17 ADGRV1 RYR2 FREM2 PTPRQ DNAH5 FAT4 FRAS1 NRCAM KIF26B SLC8A1 PIEZO2 GUCY2F UNC13C SPAG17 PLCE1 | 1.06e-13 | 184 | 347 | 17 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M SLC6A17 ADGRV1 RYR2 FREM2 PTPRQ DNAH5 FAT4 FRAS1 NRCAM KIF26B SLC8A1 PIEZO2 GUCY2F UNC13C SPAG17 PLCE1 | 1.06e-13 | 184 | 347 | 17 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M SLC6A17 ADGRV1 RYR2 FREM2 PTPRQ DNAH5 FAT4 FRAS1 NRCAM KIF26B SLC8A1 PIEZO2 GUCY2F UNC13C SPAG17 PLCE1 | 1.06e-13 | 184 | 347 | 17 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | A2M PDGFRA RYR2 TMEM132C NRXN2 PTPRQ COL5A1 ABI3BP COL6A6 KIF26B PCDHGA2 PPM1E PCDHB7 PIEZO2 PDZRN3 | 1.06e-11 | 177 | 347 | 15 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | A2M PDGFRA RYR2 TMEM132C NRXN2 PTPRQ COL5A1 ABI3BP COL6A6 KIF26B PCDHGA2 PPM1E PCDHB7 PIEZO2 PDZRN3 | 1.06e-11 | 177 | 347 | 15 | db222faaecbe5600da39277243c4e7e764eb63c9 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | A2M MAP2 TRPC4 ACTA2 ANKS1B EXT1 ACTN1 RYR2 TNC SGCD SLC8A1 SLIT3 MACF1 UNC13C PDZRN3 | 2.52e-11 | 188 | 347 | 15 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TSHZ2 ADCY9 RYR2 PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC KIF26B APOE PIEZO2 SLIT3 PDZRN3 | 2.72e-11 | 189 | 347 | 15 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | A2M PDGFRA TRPC4 RYR2 COL5A1 FRAS1 NRCAM ABI3BP COL6A6 TTC28 KIF26B SGCD PIEZO2 SLIT3 PDZRN3 | 4.24e-11 | 195 | 347 | 15 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | A2M PDGFRA TSHZ2 RYR2 COL5A1 NRCAM ABI3BP TTC28 TNC KIF26B SGCD PIEZO2 SLIT3 PDZRN3 PHLDB2 | 4.90e-11 | 197 | 347 | 15 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC KIF26B REV3L APOE SLIT3 MACF1 OSMR PDZRN3 | 6.07e-11 | 200 | 347 | 15 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | PDGFRA RYR2 PHEX TMEM132C COL5A1 ABI3BP COL6A6 TTC28 TNC REV3L APOE SLIT3 MACF1 OSMR PDZRN3 | 6.07e-11 | 200 | 347 | 15 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | A2M RYR2 PHEX TMEM132C CASS4 FRAS1 ABI3BP COL6A6 TNC SGCD LRRN3 PIEZO2 SLIT3 PDZRN3 | 1.77e-10 | 181 | 347 | 14 | 9ede19228ba5c0668a9c06c915510b95585216ef |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | A2M PDGFRA TSHZ2 RYR2 TMEM132C COL5A1 FAT4 ZEB1 NRCAM ABI3BP SGCD LEPR SLIT3 PDZRN3 | 2.72e-10 | 187 | 347 | 14 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C NRCAM ABI3BP COL6A6 TTC28 TNC KIF26B APOE PIEZO2 SLIT3 OSMR PDZRN3 | 3.85e-10 | 192 | 347 | 14 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC KIF26B SGCD APOE PIEZO2 SLIT3 PDZRN3 | 3.85e-10 | 192 | 347 | 14 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | A2M PDGFRA EXT1 RYR2 PHEX TMEM132C CASS4 COL5A1 SGCD PIEZO2 SLIT3 MACF1 PDZRN3 PHLDB2 | 4.13e-10 | 193 | 347 | 14 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | A2M PDGFRA TRPC4 RYR2 PHEX CASS4 COL5A1 ABI3BP COL6A6 KIF26B SGCD PIEZO2 SLIT3 PDZRN3 | 4.13e-10 | 193 | 347 | 14 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TSHZ2 RYR2 PHEX TMEM132C CASS4 COL5A1 FAT4 TTC28 TNC SGCD PIEZO2 SLIT3 UNC13C PDZRN3 | 4.42e-10 | 194 | 347 | 14 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | RYR2 TMEM132C CASS4 COL5A1 FRAS1 COL6A6 KIF26B SGCD PIEZO2 FHOD1 SLIT3 UNC13C PDZRN3 PLCE1 | 4.42e-10 | 194 | 347 | 14 | 35f132cc38ac133be01834ed0946188aa0757eb4 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | RYR2 IVD PHEX BSN NRCAM ABI3BP COL6A6 TNC REV3L APOE SLIT3 MACF1 OSMR PDZRN3 | 5.40e-10 | 197 | 347 | 14 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | A2M PDGFRA TSHZ2 RYR2 COL5A1 FRAS1 NRCAM ABI3BP COL6A6 KIF26B SGCD PIEZO2 SLIT3 PDZRN3 | 5.77e-10 | 198 | 347 | 14 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TSHZ2 EXT1 RYR2 TMEM132C COL5A1 FAT4 ABI3BP COL6A6 TTC28 TNC SGCD PIEZO2 SLIT3 PDZRN3 | 5.77e-10 | 198 | 347 | 14 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA RYR2 PHEX COL5A1 NRCAM ABI3BP COL6A6 TNC REV3L APOE SLIT3 MACF1 OSMR PDZRN3 | 6.17e-10 | 199 | 347 | 14 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | A2M TSHZ2 RYR2 TMEM132C COL5A1 FAT4 ABI3BP COL6A6 TTC28 TNC SGCD PIEZO2 SLIT3 PDZRN3 | 6.17e-10 | 199 | 347 | 14 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | PHEX TMEM132C CASS4 COL5A1 NRCAM ABI3BP COL6A6 TNC TEX15 APOE NMNAT3 SLIT3 MACF1 PDZRN3 | 6.59e-10 | 200 | 347 | 14 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | A2M PDGFRA RYR2 PHEX CASS4 FAT4 FRAS1 ABI3BP COL6A6 TNC LRRN3 PIEZO2 SLIT3 MACF1 | 6.59e-10 | 200 | 347 | 14 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | A2M PDGFRA RYR2 PHEX CASS4 FAT4 FRAS1 ABI3BP COL6A6 TNC LRRN3 PIEZO2 SLIT3 MACF1 | 6.59e-10 | 200 | 347 | 14 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | A2M PDGFRA TRPC4 RYR2 PHEX COL5A1 FRAS1 ABI3BP COL6A6 TNC SGCD PIEZO2 SLIT3 PDZRN3 | 6.59e-10 | 200 | 347 | 14 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | PHEX TMEM132C CASS4 COL5A1 NRCAM ABI3BP COL6A6 TNC TEX15 APOE NMNAT3 SLIT3 MACF1 PDZRN3 | 6.59e-10 | 200 | 347 | 14 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | A2M PDGFRA RYR2 PHEX CASS4 FAT4 FRAS1 ABI3BP COL6A6 TNC LRRN3 PIEZO2 SLIT3 MACF1 | 6.59e-10 | 200 | 347 | 14 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | MAP2 TSHZ2 SACS ARHGAP29 CD200 ABI3BP TTC28 TNC KIF26B APBA1 SLIT3 CDH6 PLCE1 | 1.06e-09 | 172 | 347 | 13 | 36a96714a0eb6ac438648135336c9791881ddadb |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PDGFRA TSHZ2 ACTA2 ADGRB1 MPDZ MCM5 ACTN1 TMEM132C COL5A1 NRCAM TNC MPZL1 MAGEE2 | 1.72e-09 | 179 | 347 | 13 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | A2M PDGFRA TRPC4 RYR2 COL5A1 FRAS1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 MACF1 PDZRN3 | 2.94e-09 | 187 | 347 | 13 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | A2M MAP2 TRPC4 ACTA2 ANKS1B EXT1 ACTN1 ROCK2 TNC SLIT3 MACF1 UNC13C CDH6 | 3.34e-09 | 189 | 347 | 13 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C NRCAM ABI3BP TNC KIF26B REV3L APOE PIEZO2 SLIT3 OSMR PDZRN3 | 3.56e-09 | 190 | 347 | 13 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M PDGFRA RYR2 COL5A1 FAT4 FRAS1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 MACF1 PDZRN3 | 3.80e-09 | 191 | 347 | 13 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC SGCD APOE PIEZO2 SLIT3 PDZRN3 | 4.04e-09 | 192 | 347 | 13 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C NRCAM ABI3BP COL6A6 TNC KIF26B APOE PIEZO2 SLIT3 OSMR PDZRN3 | 4.04e-09 | 192 | 347 | 13 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | CDKAL1 UBR5 PLCB1 CHD6 PLCG2 HSPA4 ROCK2 FRAS1 TTC28 RICTOR ZFC3H1 TNKS PRAME | 4.31e-09 | 193 | 347 | 13 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC KIF26B APOE PIEZO2 SLIT3 OSMR PDZRN3 | 4.58e-09 | 194 | 347 | 13 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | TSHZ2 ANKS1B EXT1 ASAP2 PLCB1 CEP126 COL5A1 ZEB1 ABI3BP TTC28 CCDC39 OPHN1 UGGT2 | 4.88e-09 | 195 | 347 | 13 | a78b605b49acd8c9d68716266ca269dafcd910b9 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | A2M PDGFRA TRPC4 RYR2 PHEX CASS4 COL5A1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 PDZRN3 | 4.88e-09 | 195 | 347 | 13 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | TSHZ2 TMEM132C COL5A1 FAT4 ABI3BP COL6A6 SGCD AFF3 PIEZO2 SLIT3 MACF1 UNC13C PDZRN3 | 5.19e-09 | 196 | 347 | 13 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M PDGFRA TSHZ2 ACTA2 RYR2 TMEM132C PLCB1 COL5A1 FAT4 ZEB1 NRCAM ABI3BP PDZRN3 | 5.52e-09 | 197 | 347 | 13 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M PDGFRA RYR2 TMEM132C COL5A1 FAT4 ABI3BP COL6A6 LRRN3 PIEZO2 SLIT3 MACF1 PDZRN3 | 5.52e-09 | 197 | 347 | 13 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | A2M PDGFRA TSHZ2 RYR2 COL5A1 ABI3BP TTC28 KIF26B SGCD PIEZO2 SLIT3 PDZRN3 PHLDB2 | 5.52e-09 | 197 | 347 | 13 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | A2M TSHZ2 RYR2 CASS4 COL5A1 FAT4 COL6A6 TNC KIF26B SGCD PIEZO2 MACF1 PDZRN3 | 5.52e-09 | 197 | 347 | 13 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | A2M PDGFRA TSHZ2 TRPC4 RYR2 COL5A1 ABI3BP COL6A6 SGCD CCDC39 PIEZO2 SLIT3 PDZRN3 | 5.86e-09 | 198 | 347 | 13 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M PDGFRA RYR2 PHEX CASS4 COL5A1 ABI3BP COL6A6 SGCD LRRN3 PIEZO2 SLIT3 MACF1 | 5.86e-09 | 198 | 347 | 13 | f1374f7a50244d59c766ac41f44c08c9117407d2 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PHEX COL5A1 ABI3BP COL6A6 TNC REV3L APOE NMNAT3 SLIT3 MACF1 OSMR PDZRN3 | 6.23e-09 | 199 | 347 | 13 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M PDGFRA RYR2 CASS4 COL5A1 ABI3BP COL6A6 SGCD LRRN3 PIEZO2 SLIT3 MACF1 PDZRN3 | 6.23e-09 | 199 | 347 | 13 | 66a79732caf2f04c09b4d9832377aa01ca477677 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC APOE NMNAT3 SLIT3 MACF1 PDZRN3 | 6.62e-09 | 200 | 347 | 13 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC APOE NMNAT3 SLIT3 MACF1 PDZRN3 | 6.62e-09 | 200 | 347 | 13 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | A2M PDGFRA ACTA2 COL5A1 FAT4 ABI3BP COL6A6 TNC SGCD LRRN3 PIEZO2 SLIT3 PDZRN3 | 6.62e-09 | 200 | 347 | 13 | c2c6f687c49ba790174b27c7b8b084af30b34c86 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TRPC4 RYR2 PHEX CASS4 COL5A1 FRAS1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 PDZRN3 | 6.62e-09 | 200 | 347 | 13 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TSHZ2 RYR2 TMEM132C COL5A1 FAT4 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 PDZRN3 PHLDB2 | 6.62e-09 | 200 | 347 | 13 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M PDGFRA TMEM132C COL5A1 FAT4 ZEB1 ABI3BP COL6A6 SGCD LEPR SLC8A1 PDZRN3 PHLDB2 | 6.62e-09 | 200 | 347 | 13 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | PHEX TMEM132C CASS4 COL5A1 NRCAM ABI3BP COL6A6 TNC TEX15 APOE SLIT3 MACF1 PDZRN3 | 6.62e-09 | 200 | 347 | 13 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | IVD PHEX TMEM132C TTC8 NRCAM ABI3BP TNC SGCD APOE PIEZO2 SLIT3 PDZRN3 | 2.03e-08 | 181 | 347 | 12 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | PDGFRA TSHZ2 ACTA2 TMEM132C PIK3CA TJP2 COL5A1 NRCAM TNC MPZL1 PDZRN3 CACNA2D3 | 2.59e-08 | 185 | 347 | 12 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | KANSL1L SSBP2 GRHL2 MTMR10 PLCB1 CDC42BPA APOO NRCAM STPG2 FARP1 WDFY3 CACNA2D3 | 3.29e-08 | 189 | 347 | 12 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M TSHZ2 TRPC4 ACTA2 MAP3K20 ACTN1 COL5A1 ZEB1 TNC AFF3 PIEZO2 SLIT3 | 3.48e-08 | 190 | 347 | 12 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C NRCAM ABI3BP COL6A6 TNC APOE PIEZO2 SLIT3 OSMR PDZRN3 | 3.69e-08 | 191 | 347 | 12 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | (3)_MNP-(3)_DC_activated|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | UPB1 MCM5 NRXN2 KIF2A CD200 ZEB1 BIRC3 LRRK1 PIEZO2 CD80 ZBTB10 PRAME | 3.69e-08 | 191 | 347 | 12 | 0353bf797c4ef237b9bb82460c173c7d03cb8883 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TSHZ2 EXT1 ACTN1 GADD45A RYR2 COL5A1 NRCAM TNC REV3L PIEZO2 OSMR PDZRN3 | 3.69e-08 | 191 | 347 | 12 | 08720998aa55131d7377c4c67c4c935865bd7d79 |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | TSHZ2 ANKS1B SSBP2 TMEM132C PLCB1 FKBP5 COL5A1 ZEB1 ABI3BP REV3L OPHN1 UGGT2 | 3.69e-08 | 191 | 347 | 12 | 70c067c54084bfb02c29bab085f4defd477194fb |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | CDKAL1 UBR5 PLCB1 CHD6 HSPA4 ROCK2 FRAS1 TTC28 RICTOR ZFC3H1 TNKS PRAME | 3.91e-08 | 192 | 347 | 12 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | A2M PDGFRA TSHZ2 ACTA2 ANKS1B TMEM132C CD200 FAT4 ZEB1 NRCAM UNC13C PDZRN3 | 3.91e-08 | 192 | 347 | 12 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M PDGFRA RYR2 COL5A1 FRAS1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 MACF1 PDZRN3 | 3.91e-08 | 192 | 347 | 12 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | A2M MAP2 RYR2 CASS4 FRAS1 COL6A6 TNC KIF26B LRRN3 PIEZO2 MACF1 PDZRN3 | 3.91e-08 | 192 | 347 | 12 | 62904f94dfce430456f05066522cbf9bd29f4d7e |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | A2M PDGFRA TSHZ2 RYR2 TMEM132C COL5A1 FAT4 ZEB1 ABI3BP TTC28 SGCD PDZRN3 | 4.14e-08 | 193 | 347 | 12 | e6b75be08e33c1de079fb5c02f0b4468128b369c |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PDGFRA TSHZ2 ACTA2 MCM5 ACTN1 TMEM132C COL5A1 NRCAM TNC MPZL1 NOP58 PDZRN3 | 4.14e-08 | 193 | 347 | 12 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | A2M RYR2 PHEX TMEM132C CASS4 COL5A1 ABI3BP SGCD PIEZO2 SLIT3 MACF1 PDZRN3 | 4.14e-08 | 193 | 347 | 12 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC SGCD APOE PIEZO2 SLIT3 PDZRN3 | 4.14e-08 | 193 | 347 | 12 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PHEX TMEM132C COL5A1 ABI3BP COL6A6 TNC SGCD APOE PIEZO2 SLIT3 PDZRN3 | 4.38e-08 | 194 | 347 | 12 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | PDGFRA TSHZ2 RYR2 TMEM132C COL5A1 ABI3BP COL6A6 KIF26B SGCD PIEZO2 SLIT3 PDZRN3 | 4.38e-08 | 194 | 347 | 12 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | A2M ANKS1B PHEX TMEM132C COL5A1 FAT4 TNC SGCD PIEZO2 FHOD1 SLIT3 UNC13C | 4.38e-08 | 194 | 347 | 12 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PHEX TMEM132C COL5A1 NRCAM ABI3BP COL6A6 TNC SGCD APOE PIEZO2 SLIT3 PDZRN3 | 4.38e-08 | 194 | 347 | 12 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | A2M ACTA2 RYR2 PHEX COL5A1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 PDZRN3 CACNA2D3 | 4.64e-08 | 195 | 347 | 12 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IQGAP1 STXBP1 PTPRF BOD1L1 HERC1 COL6A6 TTC28 NSD1 REV3L SLC8A1 MACF1 PHLDB2 | 4.64e-08 | 195 | 347 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | PDGFRA TSHZ2 ACTN1 TMEM132C COL5A1 FAT4 TTC28 SGCD AFF3 PIEZO2 SLIT3 PDZRN3 | 4.91e-08 | 196 | 347 | 12 | dca52c57ba35d9395cdbca8b881f12ece721b10f |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M PDGFRA TSHZ2 ACTA2 EXT1 ACTN1 TNC AFF3 REV3L PIEZO2 SLIT3 OSMR | 4.91e-08 | 196 | 347 | 12 | 2b36b9a40fe415917afccff99ad9c3474e087d0d |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M PDGFRA RYR2 COL5A1 ABI3BP COL6A6 SGCD LRRN3 PIEZO2 SLIT3 MACF1 PDZRN3 | 4.91e-08 | 196 | 347 | 12 | 9737a5f006d37b549f281e1863aca558e1e4dc99 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M PDGFRA RYR2 COL5A1 ABI3BP COL6A6 SGCD LRRN3 PIEZO2 SLIT3 MACF1 PDZRN3 | 4.91e-08 | 196 | 347 | 12 | cecf82cd5e0a3835d655f5e7478578674a63ce25 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TSHZ2 IGLV3-10 TMEM132C COL5A1 FAT4 ZEB1 ABI3BP SGCD LEPR SLIT3 PDZRN3 | 5.19e-08 | 197 | 347 | 12 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TRPC4 ACTA2 ACTN1 RYR2 SACS COL5A1 TNC SGCD SLC8A1 SLIT3 CDH6 PDZRN3 | 5.19e-08 | 197 | 347 | 12 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | TSHZ2 TMEM132C SPATA22 FRAS1 ABI3BP COL6A6 SGCD AFF3 PIEZO2 SLIT3 MACF1 UNC13C | 5.19e-08 | 197 | 347 | 12 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TSHZ2 TMEM132C FAT4 ABI3BP COL6A6 SGCD AFF3 PIEZO2 SLIT3 MACF1 UNC13C PDZRN3 | 5.19e-08 | 197 | 347 | 12 | 11a4c417f035e554431a8f03be13b5eefa3530c0 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | A2M PDGFRA TSHZ2 RYR2 COL5A1 NRCAM ABI3BP COL6A6 KIF26B PIEZO2 SLIT3 PDZRN3 | 5.49e-08 | 198 | 347 | 12 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TSHZ2 TMEM132C COL5A1 FAT4 ABI3BP COL6A6 TTC28 SGCD PIEZO2 SLIT3 MACF1 PDZRN3 | 5.49e-08 | 198 | 347 | 12 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | TSHZ2 ACTA2 MPDZ RYR2 COL5A1 FAT4 FRAS1 TNC KIF26B PIEZO2 UNC13C PDZRN3 | 5.80e-08 | 199 | 347 | 12 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA PHEX COL5A1 ABI3BP COL6A6 TNC REV3L APOE NMNAT3 SLIT3 OSMR PDZRN3 | 5.80e-08 | 199 | 347 | 12 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | PHEX TMEM132C CASS4 COL5A1 ABI3BP COL6A6 TNC TEX15 APOE NMNAT3 SLIT3 MACF1 | 5.80e-08 | 199 | 347 | 12 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | EXT1 SSBP2 CDKAL1 UBR5 GNAQ HERC1 UBR2 TTC28 AFF3 OPHN1 TNKS WDFY3 | 5.80e-08 | 199 | 347 | 12 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA RYR2 PHEX TMEM132C ABI3BP COL6A6 TNC REV3L APOE SLIT3 OSMR PDZRN3 | 5.80e-08 | 199 | 347 | 12 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | A2M PDGFRA RYR2 PHEX CASS4 ABI3BP COL6A6 TNC SGCD PIEZO2 SLIT3 MACF1 | 5.80e-08 | 199 | 347 | 12 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA PHEX COL5A1 ABI3BP COL6A6 TNC REV3L APOE NMNAT3 SLIT3 OSMR PDZRN3 | 5.80e-08 | 199 | 347 | 12 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | A2M PDGFRA RYR2 PHEX CASS4 ABI3BP COL6A6 TNC SGCD PIEZO2 SLIT3 MACF1 | 5.80e-08 | 199 | 347 | 12 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TSHZ2 TRPC4 RYR2 CASS4 COL5A1 ABI3BP COL6A6 SGCD PIEZO2 SLIT3 PDZRN3 | 6.13e-08 | 200 | 347 | 12 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | GDAP2 ZNF318 ADCY9 ITPR3 PTPRF C5 ZC3H7B ARMH3 CDC42BPA IFT74 AHCYL2 GPR107 FARP1 EPHA2 ELAVL1 | 3.48e-07 | 197 | 344 | 15 | 6984_DN |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | CDK19 ZNF318 NEK9 PTPRF UBR5 PLCB1 ANKRD12 HERC1 PRKAG2 COL5A1 VLDLR MACF1 AKAP11 ATM | 1.35e-06 | 191 | 344 | 14 | 4168_DN |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | GGA2 CDKAL1 PHEX PTPRB KIF3C ZC3H7B FKBP5 ZEB1 ATN1 TEX15 APOE GRM4 SYDE1 MTA1 | 2.20e-06 | 199 | 344 | 14 | 4228_DN |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; PC3; HT_HG-U133A | SNPH PDK2 PDK3 MCM5 ZNF318 ARMH3 PNPLA2 CDC42BPA BIRC3 LRRK1 BABAM2 FARP1 CDC25C COQ7 | 2.33e-06 | 200 | 344 | 14 | 5828_DN |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | KANSL1L SNPH ADGRB1 ARHGEF11 ITPR3 ZC3H7B ATN1 PCDHGA10 TNC RGS12 LRRN3 AATK CD80 WDFY3 | 2.33e-06 | 200 | 344 | 14 | 4837_UP |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | CENPE CDK19 EXT1 SSBP2 GRHL2 ADCY9 UBR5 ANKRD12 ROCK2 REV3L TTLL4 WDFY3 PDZRN3 | 2.61e-06 | 174 | 344 | 13 | 7530_DN |
| Drug | AC1NFC6P | PDGFRA ST7L GFAP PLCB1 PLCG1 PLCG2 PCDHGA11 PCDHGA10 PCDHGA3 PCDHGA2 BIRC3 PLCE1 | 2.71e-06 | 148 | 344 | 12 | CID000004587 |
| Drug | serotonin | ACTA1 ACTA2 ACTC1 MPDZ GFAP ADCY9 HP PLCB1 PLCG1 PLCG2 GNAQ FKBP5 ROCK2 CLIC3 POLRMT CIT CRK TGM4 POLR3E ELAVL1 ATM HPS5 HTT PLCE1 | 4.36e-06 | 554 | 344 | 24 | CID000005202 |
| Drug | 9-beta-D-arabinofuranosylguanine | IQGAP2 ACTA1 ACTA2 ACTC1 ACTN1 POLA2 GFAP ADCY9 IQGAP1 ITPR3 PHEX PNPT1 PLCB1 PLCG1 PLCG2 GNAQ ROCK2 EEFSEC RNASEH2A TNC XDH REV3L APOE GRM4 CIT RGS12 CRK NMNAT3 POLR3E GUCY2F PLCE1 | 5.24e-06 | 843 | 344 | 31 | CID000000765 |
| Drug | sulfosalicylic acid | 5.57e-06 | 18 | 344 | 5 | CID000007322 | |
| Drug | Sarin | MAP2 IRF2 GFAP GADD45A IQGAP1 STXBP1 HP ITM2B HSPA4 ZEB1 LAMTOR2 NRCAM MPZL1 APOE MFN1 OSMR | 8.18e-06 | 286 | 344 | 16 | ctd:D012524 |
| Drug | 5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA | DOHH ZNF318 ARHGEF11 ZC3H7B SFN COL5A1 ATN1 AHCYL2 GPR107 SYNGR1 ATM OSMR HTT | 9.62e-06 | 196 | 344 | 13 | 892_DN |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | PTDSS2 ARHGEF11 ADCY9 DLG3 KIF3C ANKRD12 PRKAG2 HSPA4 COL5A1 CDC42BPA GPR107 ATM PDZRN3 | 9.62e-06 | 196 | 344 | 13 | 6273_DN |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A | KANSL1L MPDZ MCM5 POLA2 ADCY9 PLCG1 CDC42BPA MFN1 CRK FLAD1 GEMIN4 IPO13 UGGT2 | 9.62e-06 | 196 | 344 | 13 | 6902_DN |
| Drug | chrysene | PDK2 ACTA1 MTMR10 FAT2 PTPRB UBR5 PLCB1 ANKRD12 C5 CD200 ROCK2 NRCAM ABI3BP TNC KIF26B NSD1 BTLA ACOT1 AHCYL2 HEATR1 LRRK1 DICER1 LEPR RGS12 CRK SLC45A4 ZC3H7A SLC8A1 ARHGEF40 FARP1 TNPO3 | 1.00e-05 | 871 | 344 | 31 | ctd:C031180 |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | GDAP2 KIF2A ZC3H7B COL5A1 FAT4 TNC AHCYL2 TEX15 AATK ZBTB10 WDFY3 COQ7 HTT | 1.02e-05 | 197 | 344 | 13 | 4485_DN |
| Drug | Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | PDK2 CDKAL1 FGF12 COL5A1 PNPLA2 CDC42BPA ABI3BP AHCYL2 LEPR EPHA2 ATM WDFY3 CDH6 | 1.07e-05 | 198 | 344 | 13 | 2274_DN |
| Drug | retinoic acid; Up 200; 1uM; PC3; HG-U133A | SNPH MAP3K20 ACTC1 MCM5 ITPR3 PLCB1 SHCBP1L PRKAG2 CD200 COL5A1 AHCYL2 LEPR PIEZO2 | 1.13e-05 | 199 | 344 | 13 | 447_UP |
| Drug | tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A | ACTA2 IRF2 GRHL2 CDKAL1 STXBP1 KIF3C ANKRD12 KYNU OCRL GRM4 BABAM2 SYDE1 GPR107 | 1.13e-05 | 199 | 344 | 13 | 380_DN |
| Drug | rofecoxib; Up 200; 10uM; PC3; HG-U133A | SNPH PDK2 MAP3K20 IRF2 KYNU TTC28 EPB41L5 REV3L BABAM2 SYDE1 FARP1 SYNGR1 SLIT3 | 1.20e-05 | 200 | 344 | 13 | 463_UP |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; HL60; HT_HG-U133A | ACTC1 MPDZ ADCY9 ASAP2 FOXO4 NSD1 BIRC3 SYDE1 RGS12 CRK ORM2 TNKS CDH6 | 1.20e-05 | 200 | 344 | 13 | 2434_UP |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | PDK3 MAP3K20 IVD ASAP2 SACS PLCG2 ITM2B UBR2 APOO REV3L BABAM2 MFN1 FHOD1 | 1.20e-05 | 200 | 344 | 13 | 5284_DN |
| Drug | papaverine | ADCY9 RYR2 ITPR3 PLCB1 PLCG1 PLCG2 XDH CACNA2D4 POLR3E GUCY2F CACNA2D3 PLCE1 | 1.60e-05 | 176 | 344 | 12 | CID000004680 |
| Drug | 2-chloroadenosine | 2.47e-05 | 102 | 344 | 9 | CID000008974 | |
| Drug | AC1L9GJJ | 2.83e-05 | 40 | 344 | 6 | CID000444570 | |
| Drug | U46619 | ACTC1 ADCY9 RYR2 ITPR3 PLCB1 PLCG1 PLCG2 GNAQ FGG ROCK2 CACNA2D4 GUCY2F ELAVL1 CACNA2D3 PLCE1 | 3.19e-05 | 285 | 344 | 15 | CID000005618 |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | PDK3 CDK19 ACTA2 MPDZ DLG3 CDC42BPA ABI3BP TTC28 TNC IFNAR1 SYNGR1 PLIN3 | 3.25e-05 | 189 | 344 | 12 | 1232_DN |
| Drug | 3,4-DHPA | 3.34e-05 | 5 | 344 | 3 | CID000134092 | |
| Drug | benz(a)anthracene | TSHZ2 MTMR10 GADD45A PTPRB PLCB1 SPATA22 ANKRD12 C5 FGG HERC1 CD200 SFN ROCK2 FRAS1 NRCAM ABI3BP RBBP6 TNC KIF26B NSD1 BTLA ACOT1 AHCYL2 HEATR1 LRRK1 ZFC3H1 CHORDC1 CCDC39 LEPR RGS12 CRK SLC45A4 ZC3H7A SLC8A1 ARHGEF40 AATK FARP1 ZMYM6 | 3.51e-05 | 1251 | 344 | 38 | ctd:C030935 |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | MAP3K20 IRF2 PTDSS2 PLCB1 ZC3H7B RBBP6 RGS12 TTLL4 TLR5 UGGT2 ATM CDH6 | 3.61e-05 | 191 | 344 | 12 | 6839_DN |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | ACTA2 MCM5 ACTN1 CDKAL1 RYR2 PNPLA2 ATN1 BIRC3 APOE SYDE1 MTA1 OSMR | 4.20e-05 | 194 | 344 | 12 | 4248_DN |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | MAP2 GFAP ZC3H7B VLDLR PCDHGA10 KIF26B XDH LEPR RGS12 TTLL4 TLR5 CDH6 | 4.42e-05 | 195 | 344 | 12 | 5205_UP |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | GGA2 IRF2 GDI1 ADCY9 RYR2 ZC3H7B WWP2 BABAM2 RNF14 MTA1 SPEN HDLBP | 4.64e-05 | 196 | 344 | 12 | 5288_UP |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | NEK9 PTPRB ZC3H7B CASS4 ATN1 BIRC3 APOE GPR107 MTA1 SYNGR1 ZMYM6 HDLBP | 4.64e-05 | 196 | 344 | 12 | 4208_DN |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; HL60; HT_HG-U133A | KANSL1L ARHGEF11 ADCY9 STXBP1 PLCG1 PNPLA2 UBE3B CRK SIL1 SYNGR1 GEMIN4 WDFY3 | 4.64e-05 | 196 | 344 | 12 | 2339_UP |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | DOHH GGA2 PDGFRA NEK9 CDKAL1 PCDHGA10 SGCD MTA1 TTLL4 MACF1 UGGT2 CDH6 | 4.64e-05 | 196 | 344 | 12 | 4685_UP |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | GGA2 ARHGEF11 PLCB1 DLG3 KIF2A ANKRD12 FKBP5 ZEB1 RGS12 GPR107 ATM OSMR | 4.64e-05 | 196 | 344 | 12 | 4347_DN |
| Drug | D-myo-inositol 1,4-bisphosphate | 4.77e-05 | 86 | 344 | 8 | CID000000805 | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | GGA2 GDAP2 ZNF318 ANKRD12 PLCG1 ROCK2 IFT74 WWP2 GPR107 EPHA2 UGGT2 ZMYM6 | 4.88e-05 | 197 | 344 | 12 | 7171_DN |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A | MAP3K20 PTDSS2 CDKAL1 NSD3 CLPTM1 PNPLA2 UBE3B LRRK1 BABAM2 RNF14 HTT HDLBP | 5.13e-05 | 198 | 344 | 12 | 1329_DN |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | DOHH GGA2 ARHGEF11 RYR2 NSD3 FKBP5 AHCYL2 OCRL LEPR GPR107 TTLL4 WDFY3 | 5.13e-05 | 198 | 344 | 12 | 3555_DN |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | ITPR3 ZC3H7B KYNU SFN ABI3BP BIRC3 AHCYL2 RGS12 TNKS SLAMF7 CDH6 PLCE1 | 5.13e-05 | 198 | 344 | 12 | 2559_UP |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; PC3; HT_HG-U133A | ACTA2 CDKAL1 DLG3 ZC3H7B ATN1 APOE GRM4 MTA1 WDFY3 OSMR SLAMF7 ZMYM6 | 5.13e-05 | 198 | 344 | 12 | 3987_DN |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | GGA2 PDK3 GDAP2 SSBP2 ADCY9 ITPR3 DLG3 ANKRD12 ARMH3 HSPA4 NRCAM AHCYL2 | 5.13e-05 | 198 | 344 | 12 | 6228_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | GGA2 MPDZ IRF2 ADCY9 KIF3C ARMH3 PNPLA2 CDC42BPA AHCYL2 GPR107 FHOD1 TTLL4 | 5.38e-05 | 199 | 344 | 12 | 6969_DN |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; PC3; HT_HG-U133A | DOHH GGA2 PDK3 SSBP2 ST7L FOXO4 KIF2A ITM2B KYNU ZEB1 LRRN3 PACC1 | 5.38e-05 | 199 | 344 | 12 | 4560_UP |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A | MPDZ IRF2 CLPTM1 C5 ITM2B COL5A1 HSDL2 WWP2 REV3L AKIP1 BABAM2 DICER1 | 5.38e-05 | 199 | 344 | 12 | 1808_UP |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HG-U133A | GGA2 PDK3 CDK19 MCM5 DHPS ANKRD12 ROCK2 OPA1 SYNGR1 GEMIN4 CDC25C PRAME | 5.65e-05 | 200 | 344 | 12 | 1896_DN |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | PDK2 NSD3 C5 PLCG1 HSPA4 ROCK2 LEPR RGS12 TTLL4 SYNGR1 TLR5 ZMYM6 | 5.65e-05 | 200 | 344 | 12 | 5264_DN |
| Drug | Asbestos, Crocidolite | ZNF143 IQGAP2 ACTA2 MAP3K20 ARHGEF11 GADD45A TERF2IP IQGAP1 PRDM1 CDH20 HP ANKRD12 C5 PLCG2 FGG KYNU ROCK2 COL5A1 CUX2 RBBP6 GPS1 DBNL CLIC3 NSD1 XDH BIRC3 ZFC3H1 BABAM2 RGS12 RNF14 EPHA2 ZBTB10 TAS1R2 OSMR ATP12A PLIN3 PLCE1 | 6.59e-05 | 1241 | 344 | 37 | ctd:D017638 |
| Drug | SKF83742 | 6.61e-05 | 6 | 344 | 3 | CID000130828 | |
| Drug | Araf-TC | 9.01e-05 | 94 | 344 | 8 | CID000100788 | |
| Drug | manidipine | 9.71e-05 | 95 | 344 | 8 | CID000004008 | |
| Drug | Clorocruoro Hem | 1.07e-04 | 123 | 344 | 9 | CID003518809 | |
| Drug | AC1N9TEG | 1.14e-04 | 124 | 344 | 9 | CID000000478 | |
| Drug | N-acryloxysuccinimide | 1.14e-04 | 7 | 344 | 3 | CID000181508 | |
| Drug | AC1L1JYL | PDGFRA TRPC4 ACTA1 ACTA2 ACTC1 ACTN1 ASAP2 SACS PIK3CA DHPS PLCB1 PLCG1 PLCG2 GNAQ ROCK2 BCAR1 CRK PLCE1 | 1.20e-04 | 434 | 344 | 18 | CID000005262 |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | CDKAL1 NSD3 PHEX PLCB1 ROCK2 ATN1 EPB41L5 APOE IFNAR1 ATM OSMR | 1.37e-04 | 187 | 344 | 11 | 3368_DN |
| Drug | Androgen Antagonists | 1.39e-04 | 75 | 344 | 7 | ctd:D000726 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A | CDK19 MPDZ EXT1 PRDM1 PLCB1 PLCG1 KYNU COL5A1 PCDHGA1 RGS12 AATK | 1.43e-04 | 188 | 344 | 11 | 3046_UP |
| Drug | Biliverdin hydrochloride | 1.43e-04 | 157 | 344 | 10 | CID000000251 | |
| Drug | foscarnet | ACTA1 ACTA2 ACTC1 POLA2 BSN CASS4 COL5A1 RNASEH2A POLRMT REV3L POLR3E | 1.57e-04 | 190 | 344 | 11 | CID000003414 |
| Drug | AC1L1CWO | 1.71e-04 | 35 | 344 | 5 | CID000002095 | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | SNPH SSBP2 ZNF318 TTBK2 DLG3 ABI3BP TNC IFNAR1 FARP1 TNKS CDC25C | 1.80e-04 | 193 | 344 | 11 | 1233_DN |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A | TSHZ2 PAPOLB CDHR5 EXT1 SSBP2 GRHL2 CDC42BPA XDH BIRC3 SYDE1 TTLL4 | 1.80e-04 | 193 | 344 | 11 | 3021_UP |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | GGA2 ACTA2 MAP3K20 NEK9 PNPLA2 ZEB1 AHCYL2 IFNAR1 ARHGEF40 AATK PACC1 | 1.80e-04 | 193 | 344 | 11 | 4443_DN |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; HL60; HT_HG-U133A | DOHH PDK3 ARHGEF11 HSPA4 MPZL1 NSD1 SYDE1 MFN1 SIL1 MTA1 FLAD1 | 1.80e-04 | 193 | 344 | 11 | 2563_DN |
| Drug | AC1OAGKW | PDGFRA PDK2 ACTA1 ACTA2 ACTC1 PIK3CA PLCB1 PLCG1 PLCG2 OCRL BCAR1 | 1.80e-04 | 193 | 344 | 11 | CID006857413 |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | GGA2 CDK19 MPDZ ZNF318 CLPTM1 DLG3 UBR2 ZFC3H1 FHOD1 MACF1 ATM | 1.88e-04 | 194 | 344 | 11 | 1670_DN |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | PDK2 MPDZ ARHGEF11 ABCD4 PLCB1 TTC28 KIF26B AHCYL2 ATP12A PRAME COQ7 | 1.88e-04 | 194 | 344 | 11 | 7410_UP |
| Drug | Hyaluronic Acid | PSMC2 ACTC1 GDI1 HNRNPK PIK3CA ARHGAP29 FGG XDH MFN1 GUCY2F COQ7 | 1.88e-04 | 194 | 344 | 11 | ctd:D006820 |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | SSBP2 NEK9 NSD3 PHEX KYNU FKBP5 COL5A1 CDC42BPA SGCD XDH EPB42 | 1.88e-04 | 194 | 344 | 11 | 4531_UP |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | GGA2 PDK2 PTDSS2 ARHGEF11 ADCY9 TTBK2 KIF3C FKBP5 ABI3BP KDM4A HDLBP | 1.88e-04 | 194 | 344 | 11 | 3509_DN |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.88e-04 | 194 | 344 | 11 | 2087_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HG-U133A | GGA2 PDK2 HERC1 UBR2 PNPLA2 RBBP6 AATK SYNGR1 UGGT2 WDFY3 TNPO3 | 1.97e-04 | 195 | 344 | 11 | 1949_DN |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | PDK2 PDK3 MPDZ IRF2 DMXL1 TTBK2 ARMH3 CDC42BPA TTC28 AHCYL2 CRK | 1.97e-04 | 195 | 344 | 11 | 2104_DN |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; HL60; HT_HG-U133A | ARHGEF11 PHEX FKBP5 CDC42BPA ATN1 PCDHGA1 AHCYL2 APOE CD80 TLR5 OSMR | 1.97e-04 | 195 | 344 | 11 | 6135_UP |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A | PDK2 PLCB1 ANKRD12 ZC3H7B PNPLA2 XDH APOE SYDE1 LEPR GPR107 TNKS | 1.97e-04 | 195 | 344 | 11 | 7448_UP |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A | CDKAL1 ITM2B HSPA4 CDC42BPA EPB41L5 AKIP1 BABAM2 GPR107 EPHA2 WDFY3 CDC25C | 1.97e-04 | 195 | 344 | 11 | 2808_DN |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | GGA2 IRF2 ARHGEF11 CDKAL1 PLCB1 KIF3C ANKRD12 ARMH3 CDC42BPA AHCYL2 CDH6 | 1.97e-04 | 195 | 344 | 11 | 3461_DN |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | CDK19 KIF2A KIF3C ANKRD12 PLCG2 PNPLA2 UBE3B AHCYL2 APOE RGS12 SYNGR1 | 1.97e-04 | 195 | 344 | 11 | 7406_UP |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | CDK19 CDKAL1 NSD3 ATP8B3 ATN1 PCDHGA10 SGCD APOE LEPR AATK CDH6 | 1.97e-04 | 195 | 344 | 11 | 4111_UP |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | MAP3K20 KIF2A ITM2B VLDLR ATN1 EPB41L5 RGS12 FARP1 ATM WDFY3 SPEN | 1.97e-04 | 195 | 344 | 11 | 4398_DN |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | UPB1 GGA2 MAP3K20 KIF3C C5 ARMH3 KYNU UBE3B GPR107 KDM4A WDFY3 | 1.97e-04 | 195 | 344 | 11 | 6135_DN |
| Drug | 2,4,4'-trichlorobiphenyl | KNTC1 ZFP42 PDGFRA CATSPERD CENPE TSHZ2 TOPAZ1 ANKS1B RAD21L1 ACTC1 MCM5 POLA2 NUP205 FAT2 SACS FGF12 ANKRD12 PLCG1 TDRD6 ZEB1 CDC42BPA TTC28 KIF26B PPM1E SLITRK4 EPB41L5 BIRC3 ETNPPL BABAM2 LEPR ORM1 LRRN3 SLC8A1 NOP58 ARHGEF33 CD80 ZBTB10 ATM CDC25C | 2.03e-04 | 1411 | 344 | 39 | ctd:C081766 |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | NEK9 CDKAL1 RYR2 PLCG1 KYNU ROCK2 ATN1 PCDHGA10 XDH SYDE1 RGS12 | 2.06e-04 | 196 | 344 | 11 | 4591_UP |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | KANSL1L ARHGEF11 RYR2 PLCB1 FGF12 ATN1 TTC28 AHCYL2 RGS12 TTLL4 SYNGR1 | 2.06e-04 | 196 | 344 | 11 | 990_UP |
| Drug | sodium 4-phenylbutyrate; Up 200; 100uM; HL60; HG-U133A | ST7L NSD3 DLG3 HSPA4 ROCK2 SGCD BABAM2 LEPR RGS12 IFNAR1 TLR5 | 2.06e-04 | 196 | 344 | 11 | 363_UP |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | DOHH PTDSS2 C5 PNPLA2 ZEB1 IFT74 AHCYL2 LRRK1 MFN1 GPR107 HTT | 2.06e-04 | 196 | 344 | 11 | 2914_DN |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; HL60; HT_HG-U133A | DOHH GGA2 ADCY9 KIF2A PNPLA2 LRRK1 OCRL SYDE1 MACF1 COQ7 HTT | 2.06e-04 | 196 | 344 | 11 | 2374_DN |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; MCF7; HT_HG-U133A | GGA2 PDK3 NEK9 RYR2 ZC3H7B KYNU UBE3B AHCYL2 RGS12 ZMYM6 COQ7 | 2.06e-04 | 196 | 344 | 11 | 3204_DN |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | CDK19 SACS PLCG1 HSPA4 DSG2 PPM1E GPR107 SYNGR1 ZBTB10 MACF1 ATM | 2.06e-04 | 196 | 344 | 11 | 4782_DN |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | ARHGEF11 NSD3 PHEX ZC3H7B COL5A1 CDC42BPA PCDHGA10 SYDE1 RGS12 ARHGEF40 WDFY3 | 2.06e-04 | 196 | 344 | 11 | 3416_UP |
| Drug | indomethacin, USP; Down 200; 100uM; SKMEL5; HG-U133A | TSHZ2 MPDZ SSBP2 ZC3H7B ITM2B HSPA4 FRAS1 ATN1 LEPR RGS12 SYNGR1 | 2.15e-04 | 197 | 344 | 11 | 503_DN |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | ST7L ZC3H7B COL5A1 PCDHGA10 XDH DICER1 SYDE1 SLC8A1 THBS4 SLIT3 OSMR | 2.15e-04 | 197 | 344 | 11 | 2746_UP |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A | GGA2 UBR5 PLCB1 C5 CDC42BPA IFT74 EPB41L5 AHCYL2 AATK CDC25C COQ7 | 2.15e-04 | 197 | 344 | 11 | 7365_UP |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | MAP2 NEK9 NSD3 PLCB1 FKBP5 EPB41L5 ARHGEF40 MTA1 PACC1 SLAMF7 CDH6 | 2.15e-04 | 197 | 344 | 11 | 3794_DN |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A | KANSL1L GGA2 PDK3 ACTA2 ACTC1 VLDLR FAT4 SGCD XDH TEX15 CD80 | 2.15e-04 | 197 | 344 | 11 | 5761_UP |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | PDK3 CDK19 ZNF318 PLCG1 ZC3H7B ROCK2 PNPLA2 AHCYL2 FHOD1 SYNGR1 USP33 | 2.15e-04 | 197 | 344 | 11 | 7231_DN |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | PDK2 PDK3 FAT2 ZC3H7B CD200 ROCK2 PNPLA2 XDH SYDE1 ORM2 TLR5 | 2.15e-04 | 197 | 344 | 11 | 2163_UP |
| Disease | mental development measurement | 2.97e-07 | 25 | 334 | 6 | EFO_0008230 | |
| Disease | Sarcosine measurement | 5.13e-06 | 23 | 334 | 5 | EFO_0021668 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.60e-05 | 71 | 334 | 7 | EFO_0007878, EFO_0007979 | |
| Disease | mean platelet volume | IQGAP2 ACTN1 ST7L GADD45A PLCB1 DLG3 KIF2A PLCG2 KYNU COL6A6 TTC28 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 AFF3 LEPR RGS12 SLC45A4 ARPC2 GALNT9 ZBTB10 INTS4 HTT PLCE1 | 1.68e-05 | 1020 | 334 | 28 | EFO_0004584 |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.64e-05 | 16 | 334 | 4 | C0334634 | |
| Disease | Schizophrenia | LRRTM1 ARHGEF11 GFAP STXBP1 NRXN2 HP PIK3CA PLCB1 DLG3 KIF2A WNK3 VLDLR GPS1 MPZL1 ETNPPL APOE GRM4 DICER1 OPA1 RGS12 SYNGR1 SLIT3 APOL4 ATM CDC25C | 2.91e-05 | 883 | 334 | 25 | C0036341 |
| Disease | glucose measurement | TSHZ2 ADCY9 CDKAL1 ITPR3 TMEM132C FGF12 PLCG1 HERC1 BSN CUX2 BABAM2 SLC8A1 GALNT9 KDM4A CACNA2D3 | 3.29e-05 | 380 | 334 | 15 | EFO_0004468 |
| Disease | platelet crit | ANKRD31 IQGAP2 SSBP2 ZNF318 ACTN1 ADGRV1 ST7L ARHGEF11 HNRNPK NUP205 ARHGAP29 PLCB1 MOV10 CASS4 VLDLR TTC28 AFF3 EPB41L5 RICTOR APOE LEPR MFN1 SLC45A4 ARHGEF40 TNPO3 PLCE1 | 3.68e-05 | 952 | 334 | 26 | EFO_0007985 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.31e-05 | 145 | 334 | 9 | DOID:1289 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 7.72e-05 | 8 | 334 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 7.72e-05 | 8 | 334 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 7.72e-05 | 8 | 334 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 7.72e-05 | 8 | 334 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | mucopolysaccharidosis (implicated_via_orthology) | 1.28e-04 | 2 | 334 | 2 | DOID:12798 (implicated_via_orthology) | |
| Disease | Eichsfeld type congenital muscular dystrophy | 1.28e-04 | 2 | 334 | 2 | C0410180 | |
| Disease | oncostatin-M-specific receptor subunit beta measurement | 1.28e-04 | 2 | 334 | 2 | EFO_0801860 | |
| Disease | hyperuricemia (is_implicated_in) | 1.28e-04 | 2 | 334 | 2 | DOID:1920 (is_implicated_in) | |
| Disease | testosterone measurement | CENPE TSHZ2 ANKS1B FGFRL1 ZNF318 ST7L LARP4 ADCY9 IQGAP1 IVD PTPRF UGT2A1 PLCB1 PLCG1 ATP8B3 CUX2 TTC28 SGCD XDH C16orf96 CHORDC1 LEPR OPHN1 ZC3H7A ORM1 ARHGEF40 ZBTB10 MACF1 ATP12A PCCB | 1.39e-04 | 1275 | 334 | 30 | EFO_0004908 |
| Disease | intestinal atresia (implicated_via_orthology) | 1.63e-04 | 10 | 334 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.63e-04 | 10 | 334 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement | TSHZ2 TOPAZ1 ADGRB1 ANKS1B ACTN1 ADGRV1 PTPRB PLCB1 KIF2A ZC3H7B DNAH5 CUX2 SGCD UBE3B AFF3 SELENON BABAM2 CIT RGS12 SIL1 STPG2 SLC45A4 SLC8A1 FARP1 GALNT9 AKAP11 SSBP4 CACNA2D3 HTT | 2.05e-04 | 1242 | 334 | 29 | EFO_0007878 |
| Disease | Malignant neoplasm of breast | MAGEA4 TRPC4 ACTA2 ZNF318 HEPACAM2 RXRB HNRNPK CDH20 HP PIK3CA ARHGAP29 PLCB1 BOD1L1 ZEB1 NRCAM PPM1E XDH BCAR1 LEPR GUCY2F FARP1 MACF1 PACC1 ATM SPEN HDLBP | 2.53e-04 | 1074 | 334 | 26 | C0006142 |
| Disease | lymphocyte count | IQGAP2 ARHGEF11 GRHL2 ADCY9 HNRNPK IQGAP1 NRXN2 ARHGAP31 PLCB1 GNAQ ZC3H7B KYNU FKBP5 ROCK2 FRAS1 TTC28 PCDHGB2 PCDHGA11 PCDHGA10 SGCD PCDHGA6 PCDHGA3 PCDHGA2 PCDHGA1 WWP2 NSD1 COLEC10 LEPR SLC45A4 ATM HTT PLCE1 | 3.11e-04 | 1464 | 334 | 32 | EFO_0004587 |
| Disease | myeloid leukemia (is_implicated_in) | 3.78e-04 | 13 | 334 | 3 | DOID:8692 (is_implicated_in) | |
| Disease | breast ductal carcinoma (is_implicated_in) | 3.80e-04 | 3 | 334 | 2 | DOID:3007 (is_implicated_in) | |
| Disease | Cryptophthalmos syndrome | 3.80e-04 | 3 | 334 | 2 | C0265233 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 3.80e-04 | 3 | 334 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | breast angiosarcoma (is_implicated_in) | 3.80e-04 | 3 | 334 | 2 | DOID:4511 (is_implicated_in) | |
| Disease | FRASER SYNDROME 1 | 3.80e-04 | 3 | 334 | 2 | C4551480 | |
| Disease | Polydactyly | 3.83e-04 | 117 | 334 | 7 | C0152427 | |
| Disease | mean corpuscular hemoglobin concentration | KNTC1 IQGAP2 ZNF318 GADD45A ADCY9 CDKAL1 DMXL1 TTBK2 UBR5 PIK3CA DHPS PLCB1 CC2D2A KIF2A KIF3C ANKRD12 PRKAG2 CUX2 ATN1 TTC28 C16orf96 LEPR NOP58 GALNT9 MACF1 SSBP4 | 3.90e-04 | 1105 | 334 | 26 | EFO_0004528 |
| Disease | glycoprotein measurement | 4.24e-04 | 119 | 334 | 7 | EFO_0004555 | |
| Disease | colorectal cancer (is_marker_for) | 4.40e-04 | 157 | 334 | 8 | DOID:9256 (is_marker_for) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.77e-04 | 14 | 334 | 3 | DOID:0050144 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis, age at onset | 5.91e-04 | 15 | 334 | 3 | EFO_0004847, MONDO_0004976 | |
| Disease | esterified cholesterol measurement | 6.56e-04 | 128 | 334 | 7 | EFO_0008589 | |
| Disease | blood urea nitrogen measurement | ZNF318 ADGRV1 MRPS30 CDH20 PLCB1 PRKAG2 CUX2 CDC42BPA APOE GDF7 UGGT2 HPS5 PCCB PLCE1 | 7.11e-04 | 452 | 334 | 14 | EFO_0004741 |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 7.14e-04 | 36 | 334 | 4 | DOID:0080208 (implicated_via_orthology) | |
| Disease | Tinnitus | 7.20e-04 | 130 | 334 | 7 | HP_0000360 | |
| Disease | carcinoid tumor | 7.55e-04 | 4 | 334 | 2 | EFO_0004243 | |
| Disease | Limb dystonia | 7.55e-04 | 4 | 334 | 2 | Orphanet_93957 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 7.55e-04 | 4 | 334 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | Polymorphous corneal dystrophy | 7.55e-04 | 4 | 334 | 2 | cv:C0339284 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 7.93e-04 | 37 | 334 | 4 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 8.69e-04 | 17 | 334 | 3 | C0154060 | |
| Disease | Benign neoplasm of stomach | 8.69e-04 | 17 | 334 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 8.69e-04 | 17 | 334 | 3 | C0496905 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TSHZ2 ANKUB1 TRPC4 MAP3K20 TERF2IP RYR2 MRPS30 PTPRF NRXN2 HERC1 TTC28 AFF3 BTAF1 REV3L STPG2 THBS4 AATK HPS5 PDZRN3 CACNA2D3 | 8.92e-04 | 801 | 334 | 20 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Seizures | 9.01e-04 | 218 | 334 | 9 | C0036572 | |
| Disease | syndrome (implicated_via_orthology) | 1.03e-03 | 18 | 334 | 3 | DOID:225 (implicated_via_orthology) | |
| Disease | Congenital Fiber Type Disproportion | 1.03e-03 | 18 | 334 | 3 | C0546264 | |
| Disease | Inherited neuropathies | 1.07e-03 | 40 | 334 | 4 | C0598589 | |
| Disease | erythrocyte band 7 integral membrane protein measurement | 1.25e-03 | 5 | 334 | 2 | EFO_0801584 | |
| Disease | Granulosa Cell Cancer | 1.25e-03 | 5 | 334 | 2 | C1567257 | |
| Disease | Corneal dystrophy | 1.25e-03 | 5 | 334 | 2 | cv:C0010036 | |
| Disease | hepatocellular adenoma (biomarker_via_orthology) | 1.25e-03 | 5 | 334 | 2 | DOID:0050868 (biomarker_via_orthology) | |
| Disease | Polymorphous corneal dystrophy | 1.25e-03 | 5 | 334 | 2 | C0339284 | |
| Disease | Corneal endothelial dystrophy | 1.25e-03 | 5 | 334 | 2 | cv:C5441823 | |
| Disease | pulse pressure measurement | PDGFRA ANKUB1 ACTA2 ZNF318 LARP4 NEK9 CDKAL1 NSD3 TTC8 PNPT1 ASAP2 UGT2A1 PRKAG2 ARMH3 CUX2 TTC28 SGCD WWP2 PCDHA4 COLEC10 BCAR1 APOE GRM4 CRK PIEZO2 GDF7 GALNT9 SLIT3 PLCE1 | 1.25e-03 | 1392 | 334 | 29 | EFO_0005763 |
| Disease | mitochondrial DNA measurement | CATSPERD NUP205 ITPR3 FGG APOE CIT LEPR MFN1 CRK PDZRN3 IPMK | 1.39e-03 | 328 | 334 | 11 | EFO_0006312 |
| Disease | glioblastoma (is_marker_for) | 1.53e-03 | 44 | 334 | 4 | DOID:3068 (is_marker_for) | |
| Disease | Stomach Carcinoma | 1.64e-03 | 21 | 334 | 3 | C0699791 | |
| Disease | carnitine measurement | 1.73e-03 | 76 | 334 | 5 | EFO_0010469 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.78e-03 | 152 | 334 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Congenital myopathy with fiber type disproportion | 1.86e-03 | 6 | 334 | 2 | cv:C0546264 | |
| Disease | glucagon measurement, glucose tolerance test | 1.86e-03 | 6 | 334 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 1.86e-03 | 6 | 334 | 2 | EFO_0802054 | |
| Disease | Granulomatous Slack Skin | 1.89e-03 | 22 | 334 | 3 | C0376407 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.89e-03 | 22 | 334 | 3 | DOID:0080199 (is_implicated_in) | |
| Disease | Intellectual Disability | HNRNPK PNPT1 NRXN2 SACS DHPS CUX2 ATN1 RNASEH2A AFF3 NSD1 MACF1 ZMYM6 HTT | 1.91e-03 | 447 | 334 | 13 | C3714756 |
| Disease | Major Depressive Disorder | 1.91e-03 | 243 | 334 | 9 | C1269683 | |
| Disease | Cardiomyopathy | 1.96e-03 | 47 | 334 | 4 | cv:C0878544 | |
| Disease | Alzheimer disease, educational attainment | 2.13e-03 | 247 | 334 | 9 | EFO_0011015, MONDO_0004975 | |
| Disease | Immunologic Deficiency Syndromes | 2.15e-03 | 23 | 334 | 3 | C0021051 | |
| Disease | chronic widespread pain | 2.15e-03 | 23 | 334 | 3 | EFO_0010099 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.15e-03 | 23 | 334 | 3 | C0079773 | |
| Disease | intelligence, self reported educational attainment | 2.20e-03 | 117 | 334 | 6 | EFO_0004337, EFO_0004784 | |
| Disease | Stomach Neoplasms | 2.20e-03 | 297 | 334 | 10 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 2.36e-03 | 300 | 334 | 10 | C0024623 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.41e-03 | 82 | 334 | 5 | EFO_0005658 | |
| Disease | West Syndrome | 2.44e-03 | 24 | 334 | 3 | C0037769 | |
| Disease | Hepatolenticular Degeneration | 2.44e-03 | 24 | 334 | 3 | C0019202 | |
| Disease | Dyslipidemias | 2.44e-03 | 24 | 334 | 3 | C0242339 | |
| Disease | Hepatic Form of Wilson Disease | 2.44e-03 | 24 | 334 | 3 | C1527352 | |
| Disease | Dyslipoproteinemias | 2.44e-03 | 24 | 334 | 3 | C0598784 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.46e-03 | 50 | 334 | 4 | C1449563 | |
| Disease | Endometrioma | 2.47e-03 | 161 | 334 | 7 | C0269102 | |
| Disease | Endometriosis | 2.47e-03 | 161 | 334 | 7 | C0014175 | |
| Disease | white matter hyperintensity measurement | 2.48e-03 | 302 | 334 | 10 | EFO_0005665 | |
| Disease | age at menopause | 2.48e-03 | 302 | 334 | 10 | EFO_0004704 | |
| Disease | peritonitis (biomarker_via_orthology) | 2.58e-03 | 7 | 334 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | hepatocyte growth factor activator measurement | 2.58e-03 | 7 | 334 | 2 | EFO_0008152 | |
| Disease | hepatitis C virus infection, cirrhosis of liver | 2.58e-03 | 7 | 334 | 2 | EFO_0001422, EFO_0003047 | |
| Disease | household income | 2.60e-03 | 304 | 334 | 10 | EFO_0009695 | |
| Disease | corpus collosum mid-posterior volume measurement | 2.75e-03 | 25 | 334 | 3 | EFO_0010300 | |
| Disease | hypertension | ZNF318 CDKAL1 ARHGAP31 PRKAG2 MOV10 CUX2 BCAR1 ZBTB10 KDM4A PLCE1 | 2.79e-03 | 307 | 334 | 10 | EFO_0000537 |
| Disease | Disease Exacerbation | 2.83e-03 | 165 | 334 | 7 | C0235874 | |
| Disease | inflammatory biomarker measurement | 3.08e-03 | 26 | 334 | 3 | EFO_0004872 | |
| Disease | obesity (implicated_via_orthology) | 3.26e-03 | 215 | 334 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | serum albumin measurement | ADGRV1 ADCY9 PRDM1 BSN MOGAT2 EPB41L5 APOE BABAM2 LEPR RGS12 SLC45A4 EPHA2 MACF1 SSBP4 HDLBP | 3.32e-03 | 592 | 334 | 15 | EFO_0004535 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDGYADIVDVLNSPL | 286 | Q86TX2 | |
| LILPAVDSYQKSVND | 26 | Q13166 | |
| LESEQEEYPLSKAQT | 681 | P51826 | |
| EEYPLSKAQTVAASA | 686 | P51826 | |
| NVAVKFPEITYSLDQ | 451 | Q6UWY0 | |
| LDAYAEKVANSPLSI | 46 | Q5U5X8 | |
| EKAEQYQPLTASVSL | 596 | P16452 | |
| PDASLFDAVYSLIKN | 366 | Q9UGJ0 | |
| RAAQKYAVDVTLDPA | 321 | Q6UXG8 | |
| YNSSIKSNVPADEAV | 191 | Q96KC9 | |
| PLTNLNTAFDVAEKY | 201 | P12814 | |
| AREAYTLQATSPEIK | 1346 | Q8TER5 | |
| AYKSELEEQLTPVAE | 91 | P02649 | |
| TKRITSEQALQDPYF | 321 | Q9BWU1 | |
| DPLTLQDNYSFIIEK | 531 | Q86XM0 | |
| DVALATKNAVLTYPS | 746 | Q9NQ75 | |
| YEIANSPEEAISLAK | 181 | P31947 | |
| LARNVKEAPTEYASI | 271 | Q7Z6A9 | |
| VLAKALYDNVAESPD | 6 | P56945 | |
| SSLEKSYELPDGQVI | 236 | P68133 | |
| AQEKALDTSYVILPT | 1336 | O14514 | |
| EALKNLTPYVAIEDK | 81 | Q9BPW4 | |
| QLPILLYDSDAKTDT | 61 | O95833 | |
| LYDLENLPASKDSIV | 96 | O15144 | |
| ENLEAPALATKQTYV | 891 | Q14833 | |
| ETLPIYNLSVLAVDS | 3471 | Q6V0I7 | |
| PNKTEDTIFLREYQT | 71 | P19652 | |
| LSATQIKQEPAEEYE | 721 | P54259 | |
| SQPAENISKDLYIEV | 161 | Q9NQ31 | |
| DQEFSKNITIYSLPD | 951 | Q8WXG9 | |
| SSLEKSYELPDGQVI | 236 | P62736 | |
| AEVYQQASPKDSRSL | 346 | O15085 | |
| LPSQAYEKAQESRSV | 161 | A8MVX0 | |
| TTLYQAPERAEDKAI | 476 | Q8IYW2 | |
| FVQQDIKYIPTEDVS | 526 | Q13489 | |
| VYKESLPVSGEESQL | 966 | Q9UKA4 | |
| EQPVNLSSLAQKYAE | 211 | Q96EG1 | |
| NPYIVKLSIVDDEAT | 226 | Q5T2E6 | |
| PKDEAANTLIADYVA | 186 | Q9Y6Z7 | |
| DPYITVSVKDLNGID | 186 | Q96BJ3 | |
| QDVSAEQSLEKPELY | 1051 | O60423 | |
| QPKYAVLDEATSALT | 541 | O14678 | |
| IVDSLKLDEIQPYSS | 1816 | Q6UB98 | |
| QDPETELYAVSSKLD | 191 | P33681 | |
| NVTPDYEEKSLLEAQ | 81 | Q9HBB8 | |
| KQDPELAYISSNFIT | 466 | Q9UPY3 | |
| EAAFLSVYKQLIEAP | 86 | O14529 | |
| EDYSGALETLIKQPI | 1781 | Q9Y485 | |
| SELANTAKADVPYIL | 1511 | O14578 | |
| ILKQYSSDPVIEVAE | 106 | Q9BU89 | |
| DNIVEYAKRLSATLP | 86 | Q8TBG4 | |
| AELSASSVYNLLPEK | 611 | P01023 | |
| VTPSSDEYELKIQLE | 716 | Q9UFE4 | |
| RVPNAYDKTALALEV | 246 | P46108 | |
| DDKSLNIKTDPVDIY | 1081 | P46940 | |
| LPKENFEASYNAITL | 96 | Q9H4I0 | |
| GIYISEIDPNSIAAK | 446 | Q9UPQ7 | |
| PNLALIDKQESEITY | 116 | Q9UFN0 | |
| ALESEELLVKTPGNY | 1386 | Q96L73 | |
| SAIPNDSDLTLYLVV | 681 | Q9Y5H1 | |
| LFYNVVVENLDKPSS | 466 | Q99650 | |
| SLDIEITEKNPDSYL | 241 | Q5VW38 | |
| VAAPLYLKQSDLASA | 681 | Q96HW7 | |
| PEYAVLTSTIKNEVD | 156 | P14316 | |
| NSLTVELTQDFLPYK | 211 | O60890 | |
| TALDPDSKQNALVTY | 476 | Q9Y5H2 | |
| VSAFENPYVDAIKSL | 121 | P50148 | |
| IPTAITIKDYDSNLN | 806 | Q14573 | |
| SLLEEGVKQLDTYAP | 821 | Q92621 | |
| VTNSVPEDLSLAQYL | 1201 | Q9UPP5 | |
| EATASYKEEIVHQLP | 131 | Q9Y3D8 | |
| VEATYKNPELDRIAT | 36 | Q8IWA4 | |
| ITPEEELSYKTNGLA | 271 | A5PLL1 | |
| DLIAYPSNEKTSRVN | 741 | Q7Z6G8 | |
| DQKIIYSNEPLSIVA | 1071 | Q8N7Z5 | |
| ADEPNTLNSKISYRI | 186 | Q14126 | |
| KPDNSEILSIDLTYD | 446 | Q9NRJ5 | |
| IPFNVYALKATSELD | 201 | P16234 | |
| EPNAELIYEVTLKSF | 236 | Q13451 | |
| AVSDLEEGTYQKLLP | 206 | Q9NXN4 | |
| NYASAKLSELLPEEV | 216 | Q9Y2X3 | |
| AAPTQAQADLLTVYL | 676 | Q9Y5F0 | |
| DNLPLYELKNTITVS | 171 | Q96AD5 | |
| ILPYDATRVKLSNVD | 1736 | P23467 | |
| SAKPNDSDLTLYLVV | 681 | Q9Y5G7 | |
| ADTLINQESYEKSEP | 776 | Q9Y5G7 | |
| VYAELPNAESRSKVV | 331 | P43627 | |
| LAENKFVDEYIISPS | 661 | A0AUZ9 | |
| NVNILSEPEAAYTFK | 3971 | Q86XX4 | |
| DYSLVSFIPLNIQDK | 231 | Q9H9Y4 | |
| ILETKAPYRIFQTDA | 116 | Q96LI6 | |
| DVKEVDPASNTYTLV | 166 | P43358 | |
| VIDPQADTYNLVSKR | 146 | Q8TD90 | |
| EAEKSNLAYDIVQLP | 81 | P34932 | |
| NATAKDIAPTLTLYV | 211 | P00738 | |
| DTLPYEELQGLKVAS | 841 | Q8TD19 | |
| NKPLLVDVDLSLSAY | 456 | O60524 | |
| DAPAALYQTIEENIK | 106 | Q9Y287 | |
| AALPNVYEVISKSIA | 326 | P33992 | |
| QKSGQAPVLVIYEDS | 56 | A0A075B6K4 | |
| DDNNSPITKFIIEYE | 671 | Q92823 | |
| KVDELSLYSVPEGQS | 36 | Q9BUR5 | |
| EYIVVPSSLADQDLK | 256 | Q9NXD2 | |
| AKFEIALPVANDSYL | 976 | Q38SD2 | |
| SVDLSYNKLQALAPD | 141 | Q86UE6 | |
| EEDKQPEIYLTATDL | 341 | Q17R60 | |
| LPAIDNIKYSTFEVQ | 271 | Q9HCQ5 | |
| LEASDPNAYELIQKI | 716 | Q5T655 | |
| YADGVDLTEKIPLAN | 566 | O43150 | |
| IIPSIALAYEKAESD | 831 | P54707 | |
| LTEAVLNRYNADKPS | 346 | Q2KJY2 | |
| PKAETRLYITVNDFE | 121 | Q2LD37 | |
| PEDADYTNLIKLTVT | 2531 | Q5SZK8 | |
| LTDATKNPEIIGETY | 2596 | Q5SZK8 | |
| NSIPLTFSNRKEYVE | 4671 | Q15751 | |
| LAYLDSLVKSRPEDQ | 891 | Q9UPZ3 | |
| ADLEQKVPTNYEVIA | 3151 | Q9UPA5 | |
| ASSKQADLYDETVRP | 66 | O14782 | |
| SSIDEYFSEQPLKNL | 476 | P17181 | |
| TYSVNPEDLVKDVIE | 2621 | Q9NYQ8 | |
| NYTLVVLDDISPGKE | 111 | Q8N441 | |
| YAELISQAIESAPEK | 106 | P98177 | |
| LDPDSKENAQIIYSL | 481 | Q9Y5H3 | |
| LRVSAEKEYFTVNPE | 66 | Q9Y5G2 | |
| LDKDHYTLIDQSPVA | 256 | Q9UJA9 | |
| YVSKAESTPEIAEQR | 221 | Q13098 | |
| ITIDEPNAIVSDGKY | 1211 | Q9P2S2 | |
| NPEAIVLDVDYKSGT | 246 | Q8N8J0 | |
| QSELFPKEDLSSEQY | 411 | O75164 | |
| VDIIADAAYSIFQKP | 221 | Q6YN16 | |
| DESQRQPFVKYATLI | 976 | P48357 | |
| RYILKQDVPSSLEDA | 866 | P50748 | |
| IQSPQEKEALYALTV | 71 | Q9UJY4 | |
| ARPSSEVIKDANLYI | 96 | Q15717 | |
| TQEKVTFEIYDPNLA | 1116 | P16885 | |
| AKEPTKLADVYQAEL | 106 | P14136 | |
| FYELKQAILESPVSS | 776 | Q9BUQ8 | |
| DVLIVYAKTDLAAVP | 206 | P26440 | |
| SALEVYTPKEIFVAN | 36 | O95297 | |
| VKSTAYLSPQELEDV | 371 | Q8NB16 | |
| QTNDDAILSEISYKP | 71 | A0A2R8Y4Y8 | |
| YASLDKEDLLSPINQ | 1386 | Q6R327 | |
| SKEPLQDNVIATYEE | 331 | Q53HC9 | |
| TAPNDLYLKLEDVTH | 121 | Q8NFU5 | |
| PELQSFDDIAYIRKT | 1011 | P42336 | |
| PAFLSEEKLYQETAI | 2996 | Q9UPN3 | |
| DLKYVNPETVAALLS | 301 | P30307 | |
| KALSTDSVERLPVYN | 361 | Q15119 | |
| EYTDDNALIPKNSSV | 56 | Q7Z6E9 | |
| KSSDIIEVYTDQDIP | 1081 | Q9UMZ3 | |
| AQLYIKTEEDVPETS | 1181 | Q9UMZ3 | |
| TQDEREQLYTPASLK | 36 | P41217 | |
| ETSVVNYIDQRPAAK | 261 | Q9H813 | |
| SSRYKVQDIIVNPDA | 126 | Q7RTY9 | |
| DEVLQSDLSAHYIPK | 171 | Q8WY54 | |
| ELDTIVPLESTKAYN | 301 | P05166 | |
| AVNSVSEGAKYPELV | 181 | Q9Y5H0 | |
| SAKPNDSDLTLYLVV | 681 | Q9Y5H0 | |
| LVKTAELDPSRNYIA | 91 | Q3SYC2 | |
| PAYLASDEITTVRKN | 806 | O60313 | |
| DIVYSFSNDISPNVK | 276 | Q9UN74 | |
| YANRVKELTVDPTAA | 546 | O00139 | |
| SVENFYTLVTEKPLD | 396 | Q9Y5E2 | |
| SNSIFDPDYIKELVN | 36 | Q52LW3 | |
| AKDPSVSIRYLAAVN | 2516 | Q8NFC6 | |
| LIKAIQLTYNPDESS | 86 | P02679 | |
| SFAYEVLSNPEKREL | 51 | O60884 | |
| AINPLAEEYLSKQDL | 881 | Q13315 | |
| KFYSSEPNNLREELT | 121 | Q9HCM4 | |
| DDTAKQLIPVISDYL | 2796 | P42858 | |
| VQEAYNLIKDLEPTT | 301 | A0AVF1 | |
| EFIATKSQESDYQPI | 561 | Q96LB3 | |
| LENSKREQYSISFPE | 131 | Q6ISB3 | |
| SSVQPEELIYQRSDK | 1476 | Q9P2K1 | |
| LPYDNIITDAVLSLD | 551 | Q16394 | |
| FSNIPTYLLKDVNED | 181 | Q9NXR7 | |
| SGNILVELDEAQKPY | 1006 | O14981 | |
| QLPEAALAQTTKYLE | 246 | A6NNT2 | |
| YTNGIIAKDPTSLEE | 76 | Q86UL3 | |
| YIDSTLPQAQKLTDD | 456 | Q8IZS8 | |
| LPQKDLYTAEEEAAT | 56 | Q8TD26 | |
| YSLTIPSESENIQKD | 981 | Q9Y4F1 | |
| ISAKDPDVTNNSIRY | 411 | Q9HBT6 | |
| ARELAEAVKSNYSPT | 366 | Q9UBR1 | |
| PVLQEATEVKYNASV | 1066 | Q7Z3S7 | |
| ASYPIDELVDRAKQS | 231 | Q5VV42 | |
| SLTQEVATFPDQEKY | 426 | Q9P2H0 | |
| YEAAKLLNVDPDNVV | 41 | P24522 | |
| RVDAQPVKVYADASL | 331 | P49366 | |
| DLAPDTTYLVQVQAL | 496 | P29317 | |
| EKFSDASYQSINIPV | 516 | P01031 | |
| ELAPAYAVLKSIIQA | 191 | Q99807 | |
| NPKLREAYDAVLTIT | 301 | P51841 | |
| DEIANLVPSVQYVDK | 1276 | O60503 | |
| INPEDLSQKEYSDLL | 621 | Q02410 | |
| PDVAYRVTKDAQLSA | 71 | P20908 | |
| LKGQEDAILSYEPVT | 606 | Q92796 | |
| TYIKDVTFNTNLPDA | 471 | Q9NYL2 | |
| ATAVALQEPRKLSYA | 606 | Q71RC2 | |
| AKAQALVQYLEEPLT | 106 | Q9Y2Q5 | |
| PNKTEDTIFLREYQT | 71 | P02763 | |
| LAKDPSVEVAYIGTQ | 61 | Q9UQ10 | |
| DINDNEPIFTKEVYT | 151 | P55285 | |
| IDQKFVAISDLYEPI | 376 | P31150 | |
| LGSVNKSVVPDLEYQ | 81 | A8MVW5 | |
| AEDVSDNIIAKLFPY | 231 | Q9H583 | |
| GYLDKQVPDTSVQET | 46 | Q5J8M3 | |
| NLYDALISVADPSKQ | 76 | A6NNS2 | |
| INKTLAALPDQDSFY | 281 | Q9Y613 | |
| PNAVEQASEAVYKLA | 356 | Q8NFF5 | |
| SALEANYPEILKSLI | 176 | B5MCN3 | |
| YPSVSDIFKELLQNA | 1471 | Q9NZJ4 | |
| VDTSNITIPEKLEYF | 2706 | Q92736 | |
| AYVQLLEKAAEPTLT | 626 | O00411 | |
| DDPVVQEIDVYLAKS | 6 | Q9NVU0 | |
| AYIQATLTLKVDVAP | 186 | P0C7U9 | |
| SDIPTDQYESLKAQL | 91 | O94829 | |
| SIVQIYIPAASQKDA | 1641 | Q8TDX9 | |
| NETTKNVYEEIAAPI | 56 | Q02224 | |
| ALQEAYVRVVTEKSP | 11 | Q9UJU6 | |
| IEILSSTIKPYNAED | 76 | Q9NWV4 | |
| SPKFEIYSENILNSL | 1251 | A6NMZ7 | |
| KDTINEEVIEFLSPY | 3371 | Q8TE73 | |
| YVAAQLDVLPETFTL | 1186 | P10586 | |
| SAKPNDSDLTLYLVV | 681 | Q9Y5H4 | |
| TKDENSDYTLFNLIP | 96 | P61328 | |
| ATVAAPVVKLADQDY | 916 | Q2WGJ9 | |
| TQSKPLYETIEDNDV | 396 | Q9NP92 | |
| IINADSEDPKYIINV | 101 | P35998 | |
| YAKLTLSEQQEAPAT | 376 | Q6ZW31 | |
| QDVKLYSDTAPTEDL | 556 | Q5TCS8 | |
| AKLQSSPDYLQVLEE | 816 | Q8IW52 | |
| AVPSDSQAREKLALY | 11 | P81877 | |
| ENLDKPGETQVISYE | 276 | Q9Y6N5 | |
| TTQALALIELYNAPE | 541 | Q96HN2 | |
| ALPYENIDSEIKQTL | 1706 | O60522 | |
| ISPEKEEQYIAQFTS | 276 | P78395 | |
| DIPEDNTLKETSLYQ | 216 | Q8NHS9 | |
| AKADALYPVVSAASI | 166 | O75792 | |
| ALYPNAENSKAVTAV | 681 | Q8N3T6 | |
| TENYESPEFVLKEAQ | 941 | Q6ZMQ8 | |
| IAKIEYSTDFPVNLT | 81 | Q9H3W5 | |
| NPEEAATVTSYLKLL | 796 | Q9HCE1 | |
| LTNEQDIKPVTTDYF | 2046 | Q9P212 | |
| EASKLPYDVTTEQAL | 1021 | Q13576 | |
| EYNTRIALPLATSKD | 541 | A5D8V7 | |
| KALRTDYNASVSVPD | 66 | P61978 | |
| SPISILYIDAANNVV | 421 | Q7Z4P5 | |
| ILSKLEPQIASASEY | 81 | O60664 | |
| LLEETPQDTAYNTKR | 81 | Q9BVG9 | |
| NSTEPLVKEYAAFVL | 236 | Q9H173 | |
| ELIEYQSNIKEDPSA | 316 | Q9BZQ2 | |
| LIGEIYTNDTVPKNA | 116 | O75626 | |
| KTYINSLAILDDEPV | 546 | P49221 | |
| GAQIPVDLSELKEYS | 281 | Q14181 | |
| NIYDISKAISALVPQ | 261 | Q13330 | |
| YQPDLDTILEKVTQA | 321 | O15079 | |
| ADPYEIIESFNVVAK | 331 | Q8TCS8 | |
| NPEAIVLDVDYKSGT | 246 | A4QPH2 | |
| TLKEGYISVNEINEP | 826 | Q86SQ0 | |
| VPILLDANVSTYDKI | 391 | P61764 | |
| YDIAEGKASQPSVVI | 1116 | Q5VT25 | |
| QSFLELLEYENKSPE | 86 | Q15120 | |
| PNETVDISLDVYVSK | 626 | Q01968 | |
| LAYKESNTVVLQEPV | 1666 | Q6Q759 | |
| NPSEVEVLREKVYAS | 456 | P28702 | |
| ISASPEEVYAVAKLA | 571 | O75027 | |
| SSLEKSYELPDGQVI | 236 | P68032 | |
| DKPTLYVFNAVTQDT | 81 | A6NFN9 | |
| EQDSVKVALLETNPY | 341 | O96005 | |
| YAKNSLPELSRVEAN | 246 | Q9UHD1 | |
| TFLVIYPNVSEEAKE | 711 | Q5BKX6 | |
| DSYVELASAKVRPQA | 1166 | O75094 | |
| TDPALNDLYVISTFK | 51 | P35443 | |
| ESQPYLFIKSQDVTR | 501 | Q8N2E2 | |
| KEETLAYLNIVSPFE | 131 | Q9UBS8 | |
| QEQYLSKDLTPAVTD | 376 | P57772 | |
| PYLDITLEIKAAQSV | 256 | Q9H9J4 | |
| LAVVPAYVTEDGKNT | 71 | Q6ZQY7 | |
| EIPSSLQLVNSYALE | 101 | Q6ZQY7 | |
| LKDLESIDPEFYNSI | 641 | O00308 | |
| LYIPQATINATVKED | 36 | A8MXK1 | |
| IDPDTISALEQYAAK | 176 | P52747 | |
| LDVTPKAVDLLNYTQ | 791 | Q9UDY2 | |
| AKVYVSLDQPVTALN | 291 | Q8TAM2 | |
| ALPLSEKIQYASESR | 976 | A4D1E1 | |
| DIYNINDPLKETATI | 2941 | Q8IZQ1 | |
| VQLSTDKAGVVAEYP | 281 | O14924 | |
| DYDKISSQLPESDIL | 506 | Q8NB66 | |
| TIIDEDKTAYTPVLN | 1601 | Q8NB66 | |
| DLSPVNASIIKENYE | 481 | O75970 | |
| PYSNITVREESLKFN | 1296 | Q96T58 | |
| DKTVFSQDIRYQTPL | 2351 | O60673 | |
| AAASYPEALAKIIDE | 161 | Q96MW7 | |
| DSEFLQPLYAKEIQS | 81 | Q92629 | |
| ISDELPNLTNKYAAF | 321 | Q8N412 | |
| IEESLLNPVIATYNF | 61 | Q8N801 | |
| VPSDSQAREKLALYV | 11 | Q9BWG4 | |
| TILLDLAPEDKEYQS | 1106 | O95271 | |
| NYFLDITSVKPEEIE | 541 | Q9NZV5 | |
| PDYQLLTSVFDNSIK | 271 | Q6IQ55 | |
| IKTPYQSAQRDELVA | 486 | P10266 | |
| GNLKPDTEYEVSLIS | 861 | P24821 | |
| QDDYKPSDGLLVTVN | 406 | Q9H5I5 | |
| LYVSPDDKASNEHIL | 206 | P78562 | |
| PLKNNYSEDLELASL | 1191 | P19174 | |
| VTQTDVYRADAKEIP | 1211 | O75116 | |
| LALDVYFPQISSVKD | 86 | O43759 | |
| PDVQAVLAKYDDISL | 346 | Q8TDW4 | |
| VEKNADPETTLLAYL | 16 | P47989 | |
| DLYIDQLKSQDSPEI | 816 | Q2M1Z3 | |
| NRTILKEDPANTVYS | 291 | Q9NQ25 | |
| KLPLSYLQTQDTDAA | 136 | P0DPA3 | |
| DYALVSAVATLPKQV | 446 | Q96GW9 | |
| IYQFPTDDDTIAKVN | 236 | Q9P0V9 | |
| YLFENSDQPIDLTKS | 756 | Q9NRE2 | |
| LEQLTKSPVEFVEYN | 576 | Q9NQ66 | |
| ELPTNYNEAKFITLS | 751 | Q8TE23 | |
| TFIYIDKQPEEALSQ | 391 | Q9BZ95 | |
| YEQALAKDLSIPTDA | 996 | P11137 | |
| QETVSLYLKANPEEL | 101 | P98182 | |
| TIENDTPLEELSKYV | 221 | P98182 | |
| EILERAPKDNSLYSV | 101 | Q2M218 | |
| LPQKIVGENSLEYSE | 131 | Q96MM3 | |
| LSVNQIKTEPVDYEF | 341 | P37275 | |
| SALYAIENVETNLPL | 251 | Q9Y5L0 | |
| EVNAKSSEREAYSPL | 701 | Q8N9V7 | |
| NIADYAKSEEILIPK | 71 | Q8IWR0 | |
| AELSEAEVAQSPRYK | 16 | A0A0K0K1C0 | |
| VDELPSLDSEFYKNL | 816 | Q7Z3V4 | |
| TAIVLYNEALAVDPQ | 76 | Q96AY4 | |
| LNPKDVITTRFENSY | 146 | O95789 | |
| ALEEPVDYKQSVLNV | 26 | Q9H1V8 | |
| EAVTSYQKALDLDPE | 171 | Q96EQ0 | |
| ELNPESIYSVFKVAA | 626 | Q6PGP7 | |
| SIKSEAPESVVVDYN | 466 | Q96DT7 | |
| LPKLNNLFEYAVSEE | 351 | Q13395 | |
| DYAISKPEVLSQIEQ | 136 | Q6NUN9 | |
| DLVENSYSISVPIFK | 576 | Q00341 | |
| IYDTLSKDLNNEPIS | 1931 | Q9BXT5 | |
| PAQEYTLDFIKLADV | 491 | Q9NYU1 | |
| DSKVLQPQTATYDVF | 371 | Q7Z7G0 | |
| ELGSQYTPLTIDKEA | 76 | O60602 | |
| ESNKLINLPEDYSSL | 1596 | Q8IWV8 | |
| TQKIPDQDFYASVLD | 986 | Q14679 | |
| ALRTVINEPSYKENA | 426 | P0DTE4 | |
| GTYSTLKVQPAELED | 91 | A0A5B0 | |
| PLQSSIKETVEAYEA | 1756 | O60293 | |
| AVKLESLEETNPEYA | 576 | Q5VUA4 | |
| SLEETNPEYAKIHDL | 581 | Q5VUA4 | |
| ESELSPSEKAYLNAV | 26 | Q9UBN4 | |
| LAKDSPAQIVTYDLL | 646 | Q8TEY7 | |
| DVAILTYVKENARSP | 141 | Q9NYB0 | |
| YPAAITILETAQKIA | 1126 | O95071 | |
| SQIPAAVKLTYQDAV | 1811 | O95071 | |
| FIQSTLPLKQEEYEA | 16 | Q9UGR2 | |
| NFDNPVYLKTTEEDL | 831 | P98155 | |
| APLSDEVTKSVYAAL | 251 | Q8NFZ6 | |
| SVETKQPAILYQVED | 951 | Q9BYP7 | |
| DPQEVSATVYLDKLA | 256 | P57678 | |
| APDKLEEVLSYSNVI | 81 | Q8WU03 | |
| PVDLSLVNKDENAIY | 56 | Q16719 | |
| ITIADEYDDKQPLTS | 676 | P32418 | |
| LAKEPVQNEISATYI | 191 | Q96T66 |